The QualityStocks Daily Friday, August 16th, 2024

Today's Top 3 Investment Newsletters

QualityStocks(CING) $17.6900 +268.54%

StockEarnings(AMMX) $0.2570 +127.94%

Premium Stock Alerts(GOVX) $7.0600 +110.75%

The QualityStocks Daily Stock List

Cingulate Inc. (CING)

QualityStocks, MarketBeat, MarketClub Analysis, FreeRealTime, The Stock Dork, PennyStockProphet, OTCtipReporter and InsiderTrades reported earlier on Cingulate Inc. (CING), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Cingulate Inc. (NASDAQ: CING) is a clinical-stage biopharmaceutical firm that is engaged in developing, manufacturing and commercializing treatments for neurobiological and central nervous system disorders.

The firm has its headquarters in Morristown, New Jersey and was incorporated in 2013 by Matthew N. Brams, Raul R. Silva, Craig Steven and Shane J. Schaffer. It operates as part of the pharmaceutical and medicine manufacturing industry, under the healthcare sector. The firm serves consumers in the United States.

The company develops next-generation pharmaceuticals which have been designed to improve the lives of patients suffering from conditions which are characterized by suboptimal treatment outcomes and taxing daily dosing regimens.

The enterprise uses its proprietary precision time-release drug delivery platform technology to develop its pipeline of pharmaceutical products. Its product candidates include dexmethylphenidate (CTx-1301) and dextroamphetamine (CTx-1302), which have been developed to treat ADHD (attention deficit/hyperactivity disorder). These two candidates both contain 3 releases of active pharmaceutical ingredient, combined into a small tablet dosage form. The candidates have been developed for the following core patient segments: adults (aged 18 and above), adolescents (aged 13-17) and children (ages 6-12). In addition to this, the enterprise also develops CTx-2103 for the treatment of anxiety disorders.

The company recently launched an IPO whose proceeds it intends to use for the research, development and pre-commercialization of its ADHD products and for a proof of concept study for its anxiety disorder treatment. The success and approval of these products will bring in more revenues as well as investors into the company, which will be good for its growth.

Cingulate Inc. (CING), closed Friday's trading session at $17.69, up 268.5417%, on 100,646,484 volume. The average volume for the last 3 months is 2.362M and the stock's 52-week low/high is $1.8001/$187.20.

Applied DNA Sciences (APDN)

Greenbackers, QualityStocks, MarketClub Analysis, OTCPicks, Free Hot Penny Stocks, StockMarketWatch, MarketBeat, Penny Stock Pick Alert, IRGnews Alert, Wall Street Resources, BUYINS.NET, The PennyStock Picks, Early Bird, Real Pennies, Standout Stocks, Schaeffer's, SuperNova Elite, Super Nova Stock Picks, TraderPower, StreetInsider, We Pick Penny Stocks, Liquid Tycoon, Stock Analyzer, Penny Stock MoneyTrain, StockEgg, Beacon Equity Research, Super Hot Penny Stocks, FeedBlitz, CoolPennyStocks, MicroStockProfit, HotOTC, OTCReporter, Wall Street Grand, PennyStockScholar, PennyTrader Publisher, OTCtipReporter, Trades Of The Day, PennyStockProphet, Top Stock Picks, Proactivecrg, Penny Stock Finder, INO Market Report, Penny Stock Solutions, Otcstockexchange, Penny Pick Finders, Penny Stock Chaser, Penny Performers, InvestorPlace, BullRally, INO.com Market Report, Dubai Penny Stocks, Marketbeat.com, Lebed.biz, HotPennyStocksNow, Investor Ideas, Micro Cap Pulse, Stock Rich, TradersPro, The Penny Play, Stockpalooza, StockOnion, StockHideout, Penny Stock Pick Report, SmallCapVoice, Profitable Trader Authority, PennyStockVille, PennyStocks24, PennyStockCrowd, Penny stock-pick, 24-7 Stock Alert, PennyInvest, Daily Trade Alert, StockRun, Streetwise Reports, The Online Investor, HEROSTOCKS, DrStockPick, Stockoutlaws, Daily Markets, Top Stock Tips, Buzz Stocks, Penny Stock Rumble, Trading Concepts, BoonMarket, Bloomfield Investment Club, Winning Penny Stock Picks, ThePUMPTracker, Stock Brain, OTC Stock Review, Monster Stock Alerts, Momentum Playerz, PennyPic, MicrocapVoice, PennyOmega, StockRich, Stock Beast, Stock Marketing Inc., MadPennyStocks, Stock Gumshoe, Wise Alerts, Pennybuster, Stockhunter.us, Investing Futures, Penny Stock Explosion and Penny Invest reported earlier on Applied DNA Sciences (APDN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Applied DNA Sciences Inc. (NASDAQ: APDN) (FRA: UDJP) is focused on developing and marketing technology solutions which are DNA-based that can be used in the drug manufacturing and developing markets, as well as for anti-theft, anti-counterfeiting and supply chain security applications.

The firm has its headquarters in Stony Brook, New York and was incorporated in 1983. Prior to its name change in 2002, the firm was known as Datalink Systems Inc. It operates as part of the technology sector, under the technology hardware and semiconductors industry. The firm serves consumers in Asia, Europe and the U.S.

The company is focused on offering DNA-based authentication and security solutions and services which protect intellectual property, supply chains, brands, products and assets of consumers, governments and companies from diversion, fraud, counterfeiting and theft.

The enterprise’s product authentication and security solutions include its molecular tags under the SigNature brand, which offer forensic protection and power for different applications. They can be used to strengthen brand protection efforts. This is in addition to tracking and convicting criminals. It also produces the CertainT supply chain platform which offers proof of product claims for products, items or materials; and its SigNify portable DNA readers and consumable reagent test kits, which offer real-time molecular tags authentication.

The firm recently entered into an agreement with Flora Growth to deploy its CertainT platform as part of the latter company’s product validation and authentication platform for government regulators, distributors and consumers. The move will not only bring in additional revenue into the firm but also encourage more investments into the firm.

Applied DNA Sciences (APDN), closed Friday's trading session at $0.7829, up 78.2153%, on 51,228,704 volume. The average volume for the last 3 months is 1.782M and the stock's 52-week low/high is $0.3131/$30.60.

Seelos Therapeutics (SEEL)

QualityStocks, MarketBeat, StockEarnings, StockMarketWatch, MarketClub Analysis, PsychedelicNewsWire, TradersPro, Schaeffer's, Prism MarketView, BUYINS.NET, Trades Of The Day, The Online Investor and INO Market Report reported earlier on Seelos Therapeutics (SEEL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Seelos Therapeutics Inc. (NASDAQ: SEEL) (FRA: NXEN) is a clinical-stage biopharmaceutical firm that is engaged in the development and commercialization of new technologies and treatments for respiratory disorders, central nervous system disorders as well as major depressive and post-traumatic stress disorders.

Seelos Therapeutics Inc. is based in New York and was incorporated in 2016. The firm serves patients in the United States and its portfolio is made up of late-stage clinical assets that target various movement and psychiatric disorders.

Seelos Therapeutics Inc.’s lead product candidates include intranasal ketamine indicated for the treatment of acute suicidal behavior and ideation in patients with post-traumatic stress disorder and major depressive disorder known as SLS-002; a protein stabilizer indicated for the treatment of Sanfilippo syndrome, SLS-005; a partial dopamine agonist indicated for the treatment of Parkinson’s disease dubbed SLS-006. Other preclinical programs include an injectable post-op pain management therapy named SLS-012; an oral histamine antagonist for narcolepsy and associated disorders, SLS-010; another treatment for Parkinson’s disease, SLS-004; an oral antagonist indicated for the treatment of chronic inflammation in pediatric orphan indications and asthma, SLS-008 and an inhibitor developed to help treat Parkinson’s disease patients dubbed SLS-007.

Seelos Therapeutics Inc.’s SLS-002 candidate has shown great potential in helping manage acute-suicidal-ideation-behavior for PTSD and major depressive disorder, which has no approved medications at the moment. The likelihood of the candidate being approved by the FDA after successful completion of its clinical trial is high. Mental health conditions have been on the rise and with the pandemic’s mental health effects not fully known, the drug may address a lot of the unmet medical needs that current medications on the market do not.

Seelos Therapeutics (SEEL), closed Friday's trading session at $0.4307, up 59.5185%, on 66,141,649 volume. The average volume for the last 3 months is 4.49M and the stock's 52-week low/high is $0.2212/$300.00.

Aethlon Medical (AEMD)

Tip.us, Investor Ideas, QualityStocks, StockMarketWatch, Red Chip, MarketClub Analysis, Streetwise Reports, OTCPicks, BUYINS.NET, PennyStocks24, MarketBeat, FeedBlitz, TraderPower, TradersPro, AllPennyStocks, StreetInsider, MicroCap Gems, SmallCapVoice, RedChip, Premium Stock Alerts, Pennybuster, Clutch Investments, The Online Investor, PricelessPennyStocks, PennyStockRumors.net, Stock Castle, Trading Concepts, BestStockChoice, TopPennyStockMovers, DrStockPick, Early Bird, Faisam Trader, StockBlogs, INO Market Report, PennyOmega, Investing Futures, InvestorPlace, InvestorsUnderground, SmallCapStockPlays, SmallCap Network, Nebula Stocks, PennyTrader Publisher, WallStreet Advisors, Actual Gains and Investing Daily reported earlier on Aethlon Medical (AEMD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Aethlon Medical Inc. (NASDAQ: AEMD) (FRA: EJU) is a medical technology firm that is engaged in the development of products that help in diagnosing and treating organ and life threatening ailments in the U.S.

The firm has its headquarters in San Diego, California and was incorporated in May 1998 by James A. Joyce. It is a part of the scientific and technical instruments manufacturing industry and operates in the health care industry, under the medical equipment and devices sub-industry.

The company is party to a collaboration agreement with the University of Pittsburgh which entails research on neck and head cancers. It operates through the ESI and Aethlon segments. The latter segment is involved in diagnostic business activities while the former segment deals with therapeutic business activities.

The enterprise offers a platform that develops medical equipment to target the selective removal of ailment-promoting particles from an individual’s circulatory system, known as ADAPT. Its product pipeline is made of an exosomal biomarker candidate known as TauSome, which diagnoses chronic traumatic encephalopathy in people. In addition to this, the enterprise also develops a clinical-stage immunotherapeutic device known as the Aethlon Hemopurifier, which removes life-threatening viruses and exosomes from the body’s circulatory system. These exosomes aid in the progression of infectious viral pathogens like Hepatitis C and HIV as well as cancer.

The firm recently published case studies of 2 coronavirus patients who were treated with its Hemopurifier, with its CEO noting that their device may play a crucial role in filtering out exosomes, adding that their device was able to clear the SARS-CoV-2 virus from both patients’ bloodstream. The device’s success in treating both patients may bring in more investors into the firm and push share prices higher.

Aethlon Medical (AEMD), closed Friday's trading session at $0.4056, up 26.75%, on 4,454,665 volume. The average volume for the last 3 months is 34,041 and the stock's 52-week low/high is $0.2375/$3.30.

China Yuchai (CYD)

Streetwise Reports, SmarTrend Newsletters, StocksEarning, MarketBeat, StockEarnings, TradersPro, TheStockAdvisor, Zacks, StockMarketWatch, Trading Concepts, Vantage Wire, Weekly Market Strategies, TheStockAdvisors, Barchart, Wealth Daily, PinnacleDigest, Money Morning, Marketbeat.com, InvestorPlace, Daily Trade Alert and StreetInsider reported earlier on China Yuchai (CYD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

China Yuchai International Limited (NYSE: CYD) (FRA: CYD) is a holding firm focused on manufacturing, assembling, and selling diesel and natural gas engines for buses, trucks, and passenger vehicles, industrial, marine, agriculture, construction, and generator set applications.

The firm has its headquarters in Singapore and was incorporated in 1993, on April 29th. It operates as part of the auto parts industry, under the consumer cyclical sector. The firm serves consumers around the globe, with a focus on those in the People’s Republic of China.

The company operates through the Yuchai and HL Global Enterprises Limited (HLGE) segments. The Yuchai segment manufactures on- and off-road powertrain solutions and applications. On the other hand, the HLGE segment is involved in hospitality and property development activities. The company generates the majority of its sales from the Chinese market.

The enterprise offers diesel engines comprising 4- and 6-cylinder diesel engines, high horsepower marine diesel engines, and power generator engines; natural gas engines, methanol combustion engines, diesel power generators, diesel engine parts, and remanufacturing services; as well as plug-in hybrid engines, range extenders, power generation powertrains, hybrid powertrains, integrated electric drive axel powertrains, and fuel cell systems. It also provides maintenance and retrofitting services. The enterprise distributes its engines directly to auto original equipment manufacturers, agents and retailers.

The firm recently released its latest financial results, showing increases in its revenues and gross profits. It remains committed to expanding its New Energy products and building value for its shareholders, which may positively influence its overall growth.

China Yuchai (CYD), closed Friday's trading session at $10.8, off by 2.2624%, on 36,193 volume. The average volume for the last 3 months is 58.303M and the stock's 52-week low/high is $7.83/$11.70.

Intel Corp. (INTC)

FreeRealTime, The Street, InvestorPlace, Kiplinger Today, Schaeffer's, StockMarketWatch, StreetAuthority Daily, Zacks, The Online Investor, MarketClub Analysis, Investopedia, StreetInsider, Daily Trade Alert, Trades Of The Day, TopStockAnalysts, Money Morning, MarketBeat, CNBC Breaking News, Barchart, Early Bird, Dividend Opportunities, StocksEarning, PROFIT CONFIDENTIAL, Market Intelligence Center Alert, InvestorGuide, SmarTrend Newsletters, Louis Navellier, INO Market Report, The Motley Fool, Street Insider, TheStockAdvisors, Daily Profit, ProfitableTrading, Daily Wealth, INO.com Market Report, Top Pros' Top Picks, Wyatt Investment Research, Uncommon Wisdom, The Wealth Report, TradingAuthority Daily, internetnews, TheStockAdvisor, Trading Markets, Wealth Insider Alert, internet, Money Wealth Matters, Insider Wealth Alert, Investor Guide, SiliconValley, Marketbeat.com, StrategicTechInvestor, Money and Markets, CustomerService, MarketWatch, The Best Newsletters, Investors Alley, The Street Report, Market FN, WStreet Market Commentary, DrStockPick, StreetAlerts, Cabot Wealth, GorillaTrades, Wealth Daily, DividendStocks, The Growth Stock Wire, IT News Daily, InsiderTrades, Investor Update, Daily Dividends, Daily Markets, TradingMarkets, AllPennyStocks, Investing Daily, QualityStocks, Wall Street Daily, Trading Tips, Eagle Financial Publications, StockHotTips, Forbes, CRWEWallStreet, TipRanks, ChartAdvisor, CRWEFinance, Stockhouse, Trade of the Week, Leeb's Market Forecast, Greenbackers, PennyOmega, Trading Concepts, Coattail Investor, CRWEPicks, BestOtc, Investment U, PennyToBuck, StockEarnings, Dynamic Wealth Report, InvestmentHouse, Market Authority, FeedBlitz, SmallCap Network, Super Stock Investor, The Night Owl, SwingTradeOnline, Market Intelligence Center, Darwin Investing Network, SmallCapVoice, FeedTheBull, Energy and Capital, Taipan Daily, OnTheMar, FNNO Newsletters, iStockAnalyst, Trader Prep, Wall Street Elite, Investment House, Wealthpire Inc., wyatt research newsletter, Chaikin PowerFeed, Jon Markman’s Pivotal Point, The Stock Enthusiast, The Dividend Guy, Investing Signal, Investing Lab, Willy Wizard, Market Wrap Daily, InvestorsObserver Team, SmallCapNetwork, Quant Ratings Team, Stock Gumshoe, Inside Investing Daily, Penny Stock Buzz, 24/7 Trader, StockTwits, Equities.com, InvestorIntel, Bloomfield Investment Club, Earnings360, TheOptionSpecialist, Shah's Insights & Indictments, PennyStockOracle, Wall Street Resources, INO Traders Blog, All Star Investor, Premium Stock Alerts, Wall Street Greek, Market Pulse, Short Term Wealth, Total Wealth, The Daily Market Alert, Hit and Run Candle Sticks, Millennium-Traders, FlintFreeFinance, Profitable Trader Authority, Stocks in the Spotlight, Lebed.biz and The Trading Report reported earlier on Intel Corp. (INTC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

New research has determined that artificial intelligence (AI) will transform the labor market, particularly for professionals in tech. For their research, the investigators assessed the impact of artificial intelligence on 47 roles in the tech space across the following job groups: cybersecurity, business and management, design and user experience, testing and quality assurance, software development, infrastructure and operations, and data science.

From the report, it is expected that 92% of jobs in IT will see a moderate or high transformation because of advancements in artificial intelligence. The study posits that the biggest change will be seen in entry-level and mid-level tech jobs as certain capabilities and skills become less relevant.

It is expected that AI literacy, rapid engineering, responsible AI, AI ethics and large language model architecture will become more important in this new era, while maintenance of documentation, content creation, traditional data management, research information, basic programming and languages will become easily replaceable.

This is why, the report notes, critical skills are required in tech jobs, including rapid engineering, data analytics and AI literacy. This highlights the need for workers to upskill and reskill.

The research’s findings were published by the AI-Enabled ICT Workforce Consortium. The analysis offers insight into the impact of artificial intelligence on IT jobs, given that the consortium is made up of major companies, such as Accenture, Cisco, Google, Eightfold, Indeed, IBM, Intel, SAP and Microsoft.

The consortium obtains advice from the American Federation of Labor and Congress of Industrial Organizations, Communications Workers of America, Chain5, SMEunited, Khan Academy, the European Vocational Training Association and DigitalEurope.

Cisco’s director of people, policy and purpose, Francine Katsoudas, stated that artificial intelligence represented an unparalleled opportunity for tech to benefit humanity in different ways. She revealed that the company has taken on the collective responsibility of upskilling and training 95 million individuals over the next decade.

Katsoudas noted that by investing in a long-term plan for an inclusive workforce, more could take part in and thrive in the era of artificial intelligence.

Other members of the consortium that have made training commitments include:

  • IBM, which plans to train 30 million individuals by 2030 in digital skills, including two million in artificial intelligence by the end of 2026.
  • Intel has also pledged to train more than 30 million individuals with AI skills for future and current jobs by 2030.
  • Google plans to offer more than $130 million in funding to support AI training and skills for individuals in Europe, the United States, Latin America, Africa and APAC.
  • SAP also plans to upskill two million individuals globally by 2025.
  • Microsoft has also pledged to train and certify 10 million individuals in digital skills by 2025.

Hopefully, the upskilling and reskilling envisioned by these major companies will result in fewer people losing their jobs to the AI innovations that are being brought to market by various enterprises, including Intel Corp. (NASDAQ: INTC).

Intel Corp. (INTC), closed Friday's trading session at $20.87, up 0.8699855%, on 48,582,663 volume. The average volume for the last 3 months is 2.548M and the stock's 52-week low/high is $18.84/$51.28.

SNDL Inc. (SNDL)

StockEarnings, Schaeffer's, InvestorPlace, QualityStocks, StocksEarning, MarketBeat, Trades Of The Day, BUYINS.NET, Daily Trade Alert, The Street, Kiplinger Today, StreetInsider, The Online Investor, FreeRealTime, CannabisNewsWire, Early Bird, TheoTrade, Prism MarketView, CNBC Breaking News, Investopedia, MarketClub Analysis, StockMarketWatch and MarketClub reported earlier on SNDL Inc. (SNDL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Patients with opioid-use disorder often must go above and beyond to access life-saving drugs such as methadone and suboxone as well as naloxone, the drug that reverses overdoses. In the last 10 years, opioid overdose mortality rates have increased significantly, mainly because of fentanyl in the illicit drug trade in America.

Now, a new study has determined that marijuana may help reduce the use of opioids or even stop their use completely. The study was led by Sid Ganesh, a PhD student at the School of Medicine, University of Southern California (USC).

For their study, the researchers interviewed 30 individuals who were receiving services from a methadone clinic and a syringe exchange in Los Angeles. All of them admitted that marijuana was useful in helping manage their use of opioids, partly because it had become easier to access the drug in the last couple of years.

The study also discovered that marijuana helped participants manage their withdrawal symptoms, as well as anxiety and cravings, which followed withdrawal.

This study, which was funded by the National Institute on Drug Abuse, is unique since it centers on the lived experiences of individuals who use drugs and utilized qualitative data in its analysis. Ganesh explained that qualitative research offered insight into what was effective for a certain population and why said study population was handling issues that may not present in a data point.

The study determined that 70% of the participants made less than $2,100 a month while 57% were unstably housed or unhoused. She noted that any information that could help identify the complicated relationship between opioid overdose and addiction as well as marijuana use was important.

In the last couple of years, opioid overdoses that have resulted in deaths have risen significantly, with more than 80,000 individuals dying in 2022.

Different studies suggest that the legalization of marijuana has helped decrease the consumption of opioids. However, its impact on rates of opioid overdose is mixed, with some studies determining that legal states have fewer cases of opioid overdose.

Professor Ryan Marino of Case Western Reserve University explained that it was hard to determine the influence marijuana legalization had on overdose rates. Marino, who is also an addiction medicine specialist, noted that this was mainly because of toxic drug supplies, and particularly the prevalence of fentanyl.

Marino revealed that individuals who had recently cut down on or quit opioids were especially at risk for overdose because their tolerance was lower. Marino added that while some patients successfully used marijuana to stop using opioids or at least cut down, others saw no improvements. This meant that while the treatment wasn’t effective for the majority of those struggling with opioid-use disorder, it could help some people.

Ganesh’s team reported its findings in “Drug and Alcohol Dependence Reports.”

These broader benefits of marijuana in combating the opioid crisis make the decision to end prohibition and license companies such as SNDL Inc. (NASDAQ: SNDL) a justifiable one since studies are unearthing more ways that communities are benefiting from access to legal marijuana, both medical or recreational use.

SNDL Inc. (SNDL), closed Friday's trading session at $2.22, up 0.9090909%, on 2,177,686 volume. The average volume for the last 3 months is 11.382M and the stock's 52-week low/high is $1.30/$2.93.

Bit Digital Inc. (BTBT)

QualityStocks, StocksEarning, MarketClub Analysis, Schaeffer's, TradersPro, StockEarnings, InvestorPlace, CryptoCurrencyWire, MarketBeat, Zacks, Wealth Daily, InvestorsUnderground, Early Bird and Daily Trade Alert reported earlier on Bit Digital Inc. (BTBT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Despite the ongoing downturn in the cryptocurrency market, venture capital investment remains strong, with $141.3 million invested in 20 different companies in a two-week period. Leading the charge is Morpho, which secured $50 million in a funding round led by Ribbit Capital. Other prominent investors in this round included Kraken Ventures, Brevan Howard, A16z Crypto, Pantera Capital and Coinbase Ventures.

According to data from cryptofundraising.info, an extended Series A round of $18 million was raised by Andrena, a U.S. internet service provider developing DAWN (Decentralized Autonomous Wireless Network), a decentralized broadband protocol. Dragonfly Capital led this round with participation from CMT Digital, Parfi, 6th Man Ventures, Castle Island Ventures and Wintermute Ventures.

Other notable fundraising efforts include Vessel, a DeFi initiative creating an order book trading platform driven by ZK, which raised $10 million. Cartridge, a Web3 startup, received $7.5 million, while Web3 AI game publisher Pentagon Games, which uses ZK-EVM technology, received $6 million. Pentagon Games was matched by another Web3 AI network, Deagentai, with $6 million in fundraising. Curio, a Web3 game creation business, raised $5.7 million.

Tonx, a superapp platform layer, raised $4 million, while 375ai, a startup specializing in decentralized edge data analytics, raised $5 million. In addition, $4 million was raised by the startup behind the Tokenized Liquid Note (ZTLN), Zoth. The layer two (L2) game ecosystem company Moonveil Entertainment raised $3.6 million, while Payman AI brought up the tally of the top 12 fundraisers with a $3 million raise.

Other projects that received funding include Quantlytica ($1.1 million); Lync ($1.5 million); Elmts ($2 million); Metadao and Nexio ($2.2 million each); Khalani Network and Pichi Finance ($2.5 million each); and Blockscout ($3 million). The large funding these initiatives have received indicates that investor confidence in Web3 and blockchain technology is still strong, even in the midst of the market collapse.

An earlier report by PitchBook revealed that crypto funding in the first quarter of 2024 reached $2.4 billion, marking a consecutive quarterly increase. This uptick was driven by anticipation of lower Fed rates and the launch of the first spot Bitcoin ETF in the United States, which rekindled investor interest. Funding was distributed across 518 deals, reflecting a 40.3% increase from the previous quarter, according to data from PitchBook. In contrast, venture capital fundraising hit a near-five-year decline during the same timeframe.

The enthusiasm for crypto startups has waned since its peak of more than $10 billion in early 2022, influenced by economic uncertainties and the collapse of key industry players.

This massive investment into crypto companies shows existing actors such as Bit Digital Inc. (NASDAQ: BTBT) that despite the glitches that have plagued the industry in the recent past, it is still on a growth trajectory and more investments are likely to pour into the sector.

Bit Digital Inc. (BTBT), closed Friday's trading session at $2.94, up 2.7972%, on 11,591,929 volume. The average volume for the last 3 months is 95.81M and the stock's 52-week low/high is $1.76/$5.27.

Tesla Inc. (TSLA)

The Street, Green Car Stocks, InvestorPlace, StreetInsider, Schaeffer's, Kiplinger Today, Investopedia, Zacks, MarketClub Analysis, MarketBeat, The Online Investor, Daily Trade Alert, Money Morning, Options Elite, StreetAuthority Daily, Trades Of The Day, Early Bird, Market Intelligence Center Alert, Cabot Wealth, Energy and Capital, All about trends, StocksEarning, Wealth Daily, CNBC Breaking News, TopStockAnalysts, InvestorGuide, Uncommon Wisdom, Barchart, StockEarnings, The Motley Fool, Louis Navellier, Street Insider, MarketWatch, Daily Profit, Profit Confidential, Trading Tips, AllPennyStocks, Marketbeat.com, Money and Markets, Top Pros' Top Picks, ProfitableTrading, Investors Alley, InvestorIntel, Alternative Energy, Money Wealth Matters, SmarTrend Newsletters, TipRanks, INO Market Report, Wyatt Investment Research, Wealth Insider Alert, StrategicTechInvestor, Investor Guide, Wall Street Daily, The Wealth Report, Investing Daily, FreeRealTime, Greenbackers, Investment U, CustomerService, Market Intelligence Center, smartmoneytrading, QualityStocks, The Street Report, MarketTamer, Stock Up Featured, INO.com Market Report, Wall Street Elite, Daily Wealth, Trading Concepts, Hit and Run Candle Sticks, wyatt research newsletter, Eagle Financial Publications, National Inflation Association, The Growth Stock Wire, Investiv, SureMoney, Jon Markman’s Pivotal Point, DividendStocks, StockMarketWatch, Wall Street Profit Search, GorillaTrades, Investing Futures, Short Term Wealth, Market Authority, Streetwise Reports, Insider Wealth Alert, Darwin Investing Network, Total Wealth, Stock Barometer, Investment House, equities Canada, Dynamic Wealth Report, SmallCapVoice, SmallCap Network, Rick Saddler, Chaikin PowerFeed, Bourbon and Bayonets, Average Joe Options, Rockwell Trading, Inside Investing Daily, Equities.com, The Stock Dork, TheStockAdvisors, Stock Gumshoe, The Night Owl, Dividend Opportunities, WStreet Market Commentary, The Best Newsletters, Investor News, InvestorsUnderground, Prism MarketView, The Trading Report, Daily Dividends, Lance Ippolito, Trade of the Week, FeedBlitz, Power Profit Trades, Outsider Club, Lebed.biz, BUYINS.NET, BillionDollarClub, OilAndEnergyInvestor, Wall St. Warrior, Shah's Insights & Indictments, TheOptionSpecialist, Direction Alerts, Tim Bohen, InvestorsObserver Team, Stock Tips Network, TradersPro, Contrarian Outlook, 360wallstreet, Investor Ideas, 777 Stocks, Economic News Room, GreenCarStocks, InvestmentHouse, bullseyeoptiontrading, Market Trends, Investors Underground, Market FN, Jason Bond, InsiderTrades, BullDogReporter, Smart Investing Society, The Wall Street Transcript, Terry's Tips, Trader Prep, TradeSmith Daily, TradingPub, The Weekly Options Trader, Stock Analyzer, SmallCapNetwork, Senior Resource, Visual Capitalist, Schaeffer’s, Wall Street Window and Wealthpire Inc. reported earlier on Tesla Inc. (TSLA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

If you were hoping to snag Tesla’s cybertruck priced at $61,000 with a 250-mile range, you are too late. The company has announced that it is suspending orders for this model to concentrate more on the premium version, priced at $100,000. The leading electric vehicle (EV) company has already rolled out the red carpet for the expensive cybertrucks, which are ready to be delivered as soon as this month.

So why the switch? In 2019, Tesla Inc. (NASDAQ: TSLA)‘s CEO, Elon Musk, introduced the concept of the cybertruck with a $39,900 starting price and a 500-mile range. It was meant to be a game-changer, and many people were all over it. However, the vehicle experienced several delays before being released for deliveries in late 2023. In spite of this, the company received more than a million reservations for the model. Fast-forward to today, and the demand is not so high. Industry experts believe that the reservations Musk mentioned did not accurately reflect market demands.

According to Sam Abuelsamid, an analyst at Guidehouse Insights, this might be a sign that demand isn’t quite what Tesla hoped it would be. He believes that the demand is significantly less than a million trucks. Abuelsamid added that while initially there was a lot of hype, delivering these cybertrucks at that lower price point might not be as profitable as Tesla first thought. For this reason, the company is now pushing its premium version to maximize profits.

By the end of August, you can get your hands on the $99,990 dual-motor Foundation Limited series, boasting a 318-mile range. If you are looking to splurge a little more, the $119,990 trimotor Foundation Cyberbeast is also up for grabs, offering a 301-mile range and hitting the roads in October. Given these price tags, it’s clear these vehicles are targeted for the high-end market.

However, Tesla has a plety of hurdles to overcome, even with all the buzz going around in the industry. The EV maker sold about 4,800 cybertrucks in July alone, making it the top-selling vehicle in the U.S. for vehicles priced higher than $100,000. Nevertheless, there is one big problem: keeping those sales numbers up might not be a walk in the park. Selling a cybertruck at that price point isn’t going to be easy in the long run.

Tesla Inc. (TSLA), closed Friday's trading session at $216.12, up 0.9246287%, on 88,765,122 volume. The average volume for the last 3 months is 564,664 and the stock's 52-week low/high is $138.8025/$278.98.

Curaleaf Holdings Inc. (CURLF)

InvestorPlace, QualityStocks, Kiplinger Today, MarketBeat, Cabot Wealth, Daily Trade Alert, Top Pros' Top Picks, The Online Investor, MarketClub Analysis, Profit Trends, Wealth Insider Alert, StreetInsider, CannabisNewsWire, Early Bird, Trading For Keeps, Trades Of The Day, The Street, Prism MarketView, TradersPro, Schaeffer's, Investment U, Zacks, wyatt research newsletter, Daily Profit, CFN Media Group, StreetAuthority Daily and Wyatt Investment Research reported earlier on Curaleaf Holdings Inc. (CURLF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

A recent scientific review has delved into the possible therapeutic benefits of marijuana-based medicine for treating Tourette syndrome (TS), revealing that medical cannabis might significantly help reduce the intensity of premonitory urges and tics associated with the condition.

The review’s authors examined nine studies with 401 TS patients. The findings suggest that while more research is necessary — particularly studies involving larger participant groups, standardized dosages and consistent drug formulations — marijuana-based medicine (MBM) holds promise as a treatment option for individuals with TS.

“The current study demonstrates promising and perhaps advantageous results with MBM in terms of reducing the intensity of premonitory cravings and tics,” the authors noted. They said that considering the few therapeutic choices now accessible to TS patients, these findings may be especially important.

Although there are several treatments available to lessen the frequency and intensity of tics connected to TS and improve the quality of life for patients, the authors observed a notable deficiency of strong evidence to support the efficacy of these treatments. Currently, the FDA has only approved three drugs to treat tics: aripiprazole, haloperidol and pimozide. But since there isn’t a single treatment that works for everyone, several other agents, including MBM, have been suggested as viable solutions.

The review included both cohort studies and clinical trials, and it included comparisons between measurements obtained before and after cannabis administration. The significance of the findings was evaluated using a 95% confidence interval.

The meta-analysis encompassed three trials, out of which one demonstrated a noteworthy decline in overall scores, the second showed a considerable reduction in scores and the third revealed no significant variation with the use of marijuana-based treatment.

According to the authors, their study is the first comprehensive meta-analysis and review of MBM’s efficacy in TS patients using a variety of measures. They did concede that there are questions regarding the study’s findings’ generalizability due to the very small data set and that more research is needed.

As per the Tourette Association of America, there are specific states, including Ohio, New Jersey, Missouri, Minnesota, Illinois and Arkansas, that acknowledge TS as a qualifying diagnosis for medical cannabis. In certain states, medical professionals are permitted to recommend marijuana for any disease they think would benefit from it, especially if other treatments have failed.

There is growing momentum in the United States to loosen regulations surrounding medical marijuana research. Even though reclassification by itself wouldn’t make recreational or medical cannabis markets lawful in any state, it might have several effects on government workers, taxation, research and other sectors.

The full benefits of the medical cannabis products from the thousands of licensed marijuana companies such as Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF) are unlikely to be fully known in the years to come until extensive research is done to document how different groups of patients respond when they consume these products.

Curaleaf Holdings Inc. (CURLF), closed Friday's trading session at $3.2, up 0.6289308%, on 603,547 volume. The average volume for the last 3 months is 764,867 and the stock's 52-week low/high is $2.51/$6.40.

HUB Cyber Security (HUBC)

QualityStocks, Jeff Bishop, 360 Wall Street, Premium Stock Alerts, MarketBeat, InvestorsUnderground, Investors Underground, InvestorPlace, 360wallstreet and 247 Market News reported earlier on HUB Cyber Security (HUBC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

HUB Cyber Security (NASDAQ: HUBC) (“HUB Security”), a developer of confidential computing cybersecurity solutions and services, today reported its financial results for FY 2023 ended December 31, 2023. Key financial highlights from fiscal year 2023 included revenue of $42.6 million, gross profit of $750K, operating expenses of $78.5 million, and operating loss of $(77.7) million. The company’s non-GAAP adjusted EBITDA loss for FY 2023 was $(12.2) million while operating cash flow was $(16.2) million. As of December 31, 2023, the company had cash and cash equivalents, restricted cash, and deposits of $5.2 million.

“The conclusion of the 2023 audit signifies a new chapter for HUB. Over the past eight months, we’ve significantly strengthened our market position through the acquisition of the balance of QPoint Technologies, a strategic collaboration with BlackSwan Technologies, and the addition of key executives to our team. These moves, with a pronounced reduction in debt, have expanded our reach to large enterprises and European banks, stabilized our core operations, and, based on our product and complementary partnerships, positioned HUB as a dominant force in the secured data fabric market. We believe we are now well-equipped to seize emerging opportunities and drive value for our stakeholders,” said Noah Hershcoviz, CEO of HUB.

To view the full press release, visit https://ibn.fm/9P9cd

About HUB Security Ltd.

HUB Cyber Security (“HUB Security”) was established in 2017 by veterans of the elite intelligence units of the Israeli Defense Forces. The company specializes in unique cybersecurity solutions protecting sensitive commercial and government information. The company debuted an advanced encrypted computing solution to prevent hostile intrusions at the hardware level while introducing a novel set of data theft prevention solutions. HUB Security operates in over 30 countries and provides innovative cybersecurity computing appliances as well as a wide range of cybersecurity services worldwide. For further information or inquiries, contact info@hubsecurity.com.

HUB Cyber Security (HUBC), closed Friday's trading session at $0.58, off by 10.1611%, on 2,259,701 volume. The average volume for the last 3 months is 25.051M and the stock's 52-week low/high is $0.502/$9.39899.

Alphabet Inc. (GOOGL)

The Street, InvestorPlace, Kiplinger Today, Zacks, The Online Investor, Schaeffer's, Daily Trade Alert, Investopedia, Trades Of The Day, Market Intelligence Center Alert, Money Morning, MarketBeat, Early Bird, MarketClub Analysis, StreetInsider, StreetAuthority Daily, Uncommon Wisdom, Wealth Insider Alert, Top Pros' Top Picks, Daily Profit, StrategicTechInvestor, The Street Report, Wyatt Investment Research, Wall Street Daily, The Wealth Report, Money and Markets, TopStockAnalysts, CustomerService, AllPennyStocks, Louis Navellier, MarketWatch, StocksEarning, All about trends, Investing Daily, Daily Wealth, TipRanks, ProfitableTrading, Stansberry Research, INO.com Market Report, CNBC Breaking News, Investors Alley, Marketbeat.com, INO Market Report, MarketTamer, MarketArmor.com, Market Intelligence Center, Darwin Investing Network, Power Profit Trades, Trading Tips, Stock Up Featured, QualityStocks, InvestorGuide, InsiderTrades, Options Elite, Barchart, InvestorIntel, Money Wealth Matters, Cabot Wealth, Total Wealth, Daily Dividends, SmallCapNetwork, StockEarnings, DividendStocks, The Night Owl, TheOptionSpecialist, GorillaTrades, Jon Markman’s Pivotal Point, Insider Wealth Alert, Dynamic Wealth Report, FreeRealTime, WStreet Market Commentary, The Daily Market Alert, Investiv, Investing Futures, Short Term Wealth, SmallCap Network, The Weekly Options Trader, Eagle Financial Publications, Investing Signal, Investor Guide, Trader Prep, InvestorsObserver Team, Trade of the Week, Trading Concepts, Market Authority, Average Joe Options, Investing Lab, The Motley Fool, StockMarketWatch, Smartmoneytrading, 24/7 Trader, Jim Cramer, Wealth Daily, TradingPub, Equities.com, The Wall Street Transcript, Investment House, Chaikin PowerFeed, Shah's Insights & Indictments, Financials Trends, Inside Investing Daily, Investing Breakout, Investment U, Earnings360 Newsletter, Stock Barometer, TrendAdvisor, Tradespoon, TradeSmith Daily, Traders For Cash Flow, Top Pros Top Picks, The Trading Report, The Stock Dork, RedChip, BUYINS.NET, ChartAdvisor, Profit Confidential, Lance Ippolito, Mind Over Markets, StockReport, Pennystockmania, CNBC, Contrarian Outlook, Schaeffer’s, bullseyeoptiontrading, BillionDollarClub, Beat The Street, empirefinancialresearch, Earnings360, 360 Wall Street, Day Trade Alert, Candle Stick Forum, Energy and Capital, Economic News Room, Dividend Opportunities, Energy & Resources Digest, StreetAuthority Financial, Rockwell Trading, Roundtable Roundup, SECFilings.com News, SmallCapVoice, Smart Investing Today, Smart Money Press, SmartTrading, Microcapmillionaires, Street Insider, PoliticsAndMyPortfolio.com, Summa Money, SwingTradeOnline, SystemTrading, Technology Profits Daily, Tim Bohen, Tim Sykes, wyatt research newsletter, Stock Gumshoe, Liberty Through Wealth, Greenbackers, HotStockProfits, iDigital Market and Inside Trading reported earlier on Alphabet Inc. (GOOGL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Alphabet (NASDAQ: GOOGL) (NASDAQ: GOOG), known widely for its subsidiary Google, is currently navigating through a challenging phase in the stock market, as indicated by its record-setting weekly losing streak. This trend underscores the growing apprehensions among investors regarding the company’s future prospects. Alphabet, a giant in the tech industry, faces stiff competition, regulatory hurdles, and issues tied to its social media ventures, which collectively contribute to the negative sentiment surrounding its stock.

Despite these challenges, Alphabet recently experienced a positive shift in its stock price, which increased by $2.59 or 1.61%, closing at $163.89. This uptick is a notable deviation from the downward trend, suggesting a potential resilience or recovery in investor confidence. The stock’s performance during the trading session, with fluctuations between $161.13 and $165.06, reflects the ongoing volatility and the mixed reactions from the market.

Over the past year, GOOGL’s shares have seen a wide range of prices, from as low as $120.21 to as high as $191.75. This variability highlights the stock’s sensitivity to both internal factors, such as company performance and strategic decisions, and external influences like market trends and economic conditions. The company’s substantial market capitalization of approximately $2.03 trillion underscores its significant impact on the tech sector and the broader market.

The trading volume for Alphabet Inc. on the day in question stood at about 11.85 million shares, indicating a high level of activity and interest in the stock. This level of trading activity can be attributed to the various factors affecting the company, including the investor concerns that have led to its recent losing streak. Despite these challenges, the company’s ability to maintain a high market capitalization and attract substantial trading volume speaks to its foundational strength and the enduring interest from investors.

In summary, Alphabet Inc. is at a critical juncture, facing pressures from competition, regulatory challenges, and social media-related issues, which have contributed to its stock’s recent performance woes. However, the slight increase in its stock price and the resilience in its market capitalization and trading volume suggest that there may still be a positive outlook for the company among some investors. As Alphabet navigates through these challenges, it will be crucial to monitor how these factors continue to influence its stock performance and investor sentiment.

To view the company’s latest earnings release, visit https://ibn.fm/1vFFk

About Alphabet Inc.

Alphabet is a collection of companies, the largest of which is Google. Larry Page and Sergey Brin founded Google in September 1998 and the company is headquartered in Mountain View, Calif. Billions of people use its wide range of popular products and platforms each day, like Search, Ads, Chrome, Cloud, YouTube and Android. For more information, visit the company’s website at www.ABC.xyz.

Alphabet Inc. (GOOGL), closed Friday's trading session at $162.96, up 1.0291%, on 24,208,647 volume. The average volume for the last 3 months is 210,625 and the stock's 52-week low/high is $120.2057/$191.75.

The QualityStocks Company Corner

Lexaria Bioscience Corp. (NASDAQ: LEXX)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (NASDAQ: LEXX).

Lexaria, a global innovator in drug delivery platforms, is exploring its patented DehydraTECH(TM) technology for the oral delivery of glucagon-like peptide-1 ("GLP-1") drugs.

GLP-1 drugs have shown great promise in addressing diabetes and obesity, with nearly all the major brands administered only through injection devices.

A previous human study by Lexaria evidenced improved bioavailability when semaglutide was administered orally, as compared to standard Rybelsus®.

Lexaria has several additional R&D studies underway, including both animal and human investigations into semaglutide, liraglutide and tirzepatide. Together, those three drugs represent more than 90% of all revenue in the current global GLP1 market.

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently hired a Contract Research Organization ("CRO") for its third human pilot study. "This marks a milestone for the company, notably since it announced its focus solely on glucagon-like peptide 1 (‘GLP-1') studies for the 2024 calendar year… This randomized, crossover investigation will evaluate a dual-action GLP-1 + glucose-dependent insulintropic peptide (‘GIP'), specifically measuring absorption, tolerability, pharmacokinetics, and blood sugar levels. It will compare injected tirzepatide (Zepbound(R) by Eli Lilly) to a compound formulated, DehydraTECH-processed tirzepatide derived from Zepbound(R). The objective would be to evaluate whether DehydraTECH-processed tirzepatide, when taken orally, offers any absorption into the human bloodstream and, if so, how much," a recent article reads. "Lexaria's latest study in an oral capsule hopes to evidence improved tolerability while also producing measurable quantities of drug in blood. This will be Lexaria's first-ever work with the tirzepatide molecule and, as such, any noteworthy delivery of tirzepatide through oral delivery could be a significant finding," said Chris Bunka, Lexaria's CEO.

To view the full article, visit https://ibn.fm/VpJ54

Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global innovator in drug delivery platforms. The company’s patented technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules. DehydraTECH promotes fast-acting, less expensive and more effective oral drug delivery and has been thoroughly evaluated through in vivo, in vitro and human clinical testing.

DehydraTECH is covered by 21 issued and more than 50 pending patents in over 40 countries around the world. Lexaria’s first patent was issued by the U.S. Patent and Trademark Office in October 2016 (US 9,474,725 B1), providing 20 years of patent protection expiring June 2034. Multiple patents have been awarded since then and are expected in the future.

Lexaria has also collaborated with the National Research Council (NRC), the Canadian government’s premier research and technology organization. The company has been granted patent protection for specific delivery of nicotine, vitamins, NSAIDs, antiviral drugs, cannabinoids and more.

Lexaria began developing DehydraTECH in 2014 and has since continued to strengthen and broaden the technology. The company has no plans to create or sell Lexaria-branded products containing controlled substances. Instead, Lexaria licenses its technology to other companies around the world to offer consumers the best possible performance across an array of ingestible product formats.

The company’s technology is best thought of as an additional layer that providers of consumer supplements, prescription and non-prescription drugs, nicotine and CBD products can utilize to improve the effectiveness of their own existing or planned new offerings. Lexaria has licensed DehydraTECH to multiple companies, including a world-leading tobacco producer for the research and development of smokeless, oral-based nicotine products, and for use in industries that produce cannabinoid beverages, edibles and oral products.

DehydraTECH is suitable for use with a wide range of product formats including pharmaceuticals, nutraceuticals, consumer packaged goods and over-the-counter capsules, pills, tablets and oral suspensions.

DehydraTECH Technology

Lexaria’s DehydraTECH is designed specifically for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients. DehydraTECH increases their effectiveness and improves the way active pharmaceutical ingredients enter the bloodstream. The major benefits to a subject ingesting a DehydraTECH-enabled drug or consumer product can be summarized by the following:

  • Speeds up delivery – the effects of the product are felt by the subject in just minutes.
  • Increases bioavailability – the technology is much more effective at delivering a drug or product into the bloodstream.
  • Increases brain absorption – animal testing suggests significant improvement in the quantity of drug delivered across the blood-brain barrier.
  • Improves drug potency – more of the ingested product is made available to the body, so lower doses are required to achieve the desired effect.
  • Reduces drug administration cost – lower doses mean lower overall drug costs.
  • Masks unwanted taste – the technology eliminates or reduces the need for sweeteners.

Lexaria has demonstrated in animal studies a propensity for DehydraTECH technology to elevate the quantity of drug delivered across the blood-brain barrier by as much as 1,900 percent, initiating additional new patent applications and opening possibilities for improved drug delivery.

Since 2016, DehydraTECH has repeatedly demonstrated, with cannabinoids and nicotine, the ability to increase bio-absorption by up to five to 10 times, reduce time of onset from one to two hours to just minutes, and mask unwanted tastes. The technology is to be further evaluated for additional orally administered bioactive molecules, including antivirals, cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs) and nicotine.

Market Outlook

Lexaria’s ongoing research and development efforts are mainly focused on development of product candidates across several key segments:

  • Oral Cannabinoids – a market estimated to be worth $18.4 billion in 2021 and expected to reach $46.2 billion by 2025.
  • Antivirals – an estimated $52.1 billion market in 2021 that’s expected to grow to $66.7 billion by 2025.
  • Oral Mucosal Nicotine – smokeless tobacco products, a $13.6 billion market in 2018, is forecast to grow at 7.2 percent annually through 2025.
  • Human Hormones – estrogen and testosterone replacement therapies represented a $21.9 billion market in 2019, with a forecast CAGR of 7.7 percent through 2027.
  • Ibuprofen and Naproxen – NSAID sales totaled $15.6 billion globally in 2019 and are projected to reach $24.4 billion by 2027.
  • Vitamin D3 – the global market size was $1.1 billion in 2021, growing at 7 percent per year and expected to reach $1.7 billion in 2026.

Management Team

Chris Bunka is Chairman and CEO of Lexaria Bioscience Corp. He is a serial entrepreneur who has been involved in several private and public companies since the late 1980s. He has extensive experience in the capital markets, corporate governance, mergers and acquisitions, as well as corporate finance. He is named as an inventor on multiple patent innovations.

John Docherty, M.Sc., is the President of Lexaria. He is a pharmacologist and toxicologist, and a specialist in the development of drug delivery technologies. He is the former president and COO of Helix BioPharma Corp. (TSX: HBP). He is named as an inventor on multiple issued and pending patents.

Greg Downey is Lexaria’s CFO. He has more than 35 years of diverse financial experience in the mining, oil and gas, manufacturing, and construction industries, and in the public sector. He served for eight years as CFO for several public companies and has provided business advisory and financial accounting services to many large organizations.

Gregg Smith is a strategic advisor to Lexaria. He is a founder and private investor with Evolution VC Partners. He is a member of the Sand Hill Angels and held previous investment banking roles with Cowen and Company and Bank of America Merrill Lynch.

Dr. Philip Ainslie serves as a scientific and medical advisor to Lexaria. He is co-director for the Centre for Heart, Lung and Vascular Health, Canada. He is also Research Chair in Cerebrovascular Physiology and Professor at the School of Health and Exercise Sciences, Faculty of Health and Social Development at the University of British Columbia.

Lexaria Bioscience Corp. (LEXX), closed Friday's trading session at $3.18, up 0.952381%, on 88,855 volume. The average volume for the last 3 months is 39,319 and the stock's 52-week low/high is $0.844/$6.85.

Recent News

Starco Brands Inc. (OTCQB: STCB)

The QualityStocks Daily Newsletter would like to spotlight Starco Brands Inc. (OTCQB: STCB).

Starco Brands (OTCQB: STCB), a developer and acquirer of behavior-changing technologies and brands that spark excitement in the everyday, has announced approval by its board of the company's Insider Trading Policy and plans for insiders to buy-back stock. The announcement noted that all five of the company's portfolio brands have seen year-to-date growth, with two of the divisions expected to double year over year through 2024.

"As our public company continues to grow and gain in popularity, the employees and senior executives are eager to own more of our stock," said Starco Brands chair and CEO Ross Sklar in the press release. "We are proud to announce the approval of our Insider Trading Policy and plan to buy our stock along this amazing journey. . . . I am a buyer of our stock and have begun purchasing when allowed during nonblack out periods, as outlined in our Insider Trading Policy."

To view the full press release, visit https://ibn.fm/4ifpB

Starco Brands Inc. (OTCQB: STCB) is a modern-day invention factory. The company’s unwavering mission is to invent and acquire consumer products and brands with behavior-changing technologies that spark excitement in the everyday.

This consumer product company has grown from a few million dollars in revenue to a current run rate of approximately $67 million in annual revenue in one year.

The company has succeeded by identifying whitespaces in eight core consumer categories and then either: 1) leveraging its internal R&D capabilities and dedicated manufacturing network to invent new technologies and brands or 2) utilizing the management team’s extensive M&A experience to acquire brands that fill the industry void, delighting consumers and retailers alike.

Whether the brand is developed internally or acquired, the company employs a modern marketing playbook to ensure its brands are at the forefront of culture; garnering unprecedented media attention and engagement that supports a robust sales network.

Starco Brands’ core competencies are inventing technologies, acquiring companies, marketing, building trends, pushing awareness, penetrating media (social and otherwise) and executing cutting edge pull-through strategies with a roster of globally recognized celebrities, influencers and media and distribution partners.

A commitment to changing the way people approach everyday activities is innate in the company’s corporate DNA.

The company is based in Santa Monica, California.

Brands

Whereas other consumer products companies are content with evolution, Starco Brands has its mind set on creating a revolution across the industry. From disrupting the spirits industry with Whipshots, the world’s only vodka-infused whipped cream, to Soylent, the original food tech company, Starco Brands is putting the CPG world on notice. Its portfolio of brands includes:

  • Whipshots is a first-of-its-kind alcoholic whipped cream launched in 2021 with celebrity partner Cardi B. Consumers have embraced this boozy concoction, putting it on top of cocktails, coffees and desserts, or enjoying it straight from the can. In just over a year, the brand has sold over 2 MILLION cans, making it one of the fastest growing spirits in history.
  • Winona Pure gives consumers movie theatre popcorn in the comfort of their own homes. All the flavor and none of the additives is the story behind these all-natural, non-GMO popcorn seasoning sprays. A simple spray is all it takes to add the perfect pop of flavor to the classic theatre treat.
  • Art of Sport, co-founded by the great Kobe Bryant, is the number one body care brand for athletes. With a growing line of personal care products tested by the world’s greatest athletes, these daily skin essentials give consumers everything they need to feel fresh, stay protected and confident and perform at their peak every day.
  • Skylar is the first and only line of perfumes on the market that are hypoallergenic and safe for sensitive skin. With the strong support of industry titan Sephora, the brand has quickly attracted a loyal following.
  • Soylent is a technological feat. Originally funded by Google Ventures and Andreessen Horwitz, Soylent is dubbed as the world’s most perfect food. Made from sustainably grown plant-based ingredients, Soylent’s line of products is scientifically developed to provide all the functional ingredients, vitamins, minerals, fats, carbohydrates and protein that the body needs – all in convenient, delicious and affordable packages. Soylent’s innovative product line-up includes complete nutrition powders, ready-to-drink shakes, 100-calorie snack bars, high protein nutrition shakes and energy boosting nutrition shakes. Soylent was also the recipient of the 2023 Product of the Year Award by Kantar, a global leader in consumer research.

With award-winning marketing talent, Starco Brands develops robust, integrated marketing plans for every brand in its portfolio, ensuring an impactful presence across all verticals.

Market Outlook

Starco Brands’ varied brand portfolio gives it access to the growth of numerous product categories that are ripe for innovation.

Through its February 2023 acquisition of complete nutrition pioneer Soylent, Starco Brands is positioned to capitalize on the projected growth of the plant-based nutrition space. Research firm Statista valued the plant-based nutrition market at $29.4 billion in 2020 and forecasts its value at nearly $162 billion by 2030, representing a CAGR of 18.7% for the period.

Likewise, Starco Brands gained improved access to the global fragrance market through its December 2022 acquisition of Skylar. According to a report by Grand View Research, the global perfume market was valued at $50.85 billion in 2022 and is expected to grow to a value of nearly $80 billion by 2030, achieving a CAGR of 5.9% over the forecast period.

The company is primed to expand its access to other growth verticals as it advances on its path to invent and acquire behavior-changing technologies and brands.

Management Team

Ross Sklar is the CEO of Starco Brands. A chemical formulator by trade, he started his first company while still in college. Since 2004, he has made over a dozen acquisitions with multiple exits and controls an eclectic collection of industrial, household, personal care and food and beverage manufacturers covering many consumer-packaged goods categories.

Darin Brown is the Chief Operating Officer of Starco Brands. With over 20 years of experience in chemical manufacturing, business development, finance and mergers and acquisitions, he has scaled the company from the ground up. He oversees all internal operations for Starco Brands and is an integral liaison between the company and Mr. Sklar’s manufacturing facilities.

David Dreyer is Chief Marketing Officer of Starco Brands. With over 25 years of experience working with blue chip and startup brands, he oversees all marketing initiatives for the company. Mr. Dreyer comes to Starco having worked with such standout brands as Apple, Pepsi, Pizza Hut, Dr Pepper, Snapple, Infiniti, The GRAMMY’s, Honda and Stamps.com. He is also a Professor of Advertising at USC’s Annenberg School for Communication.

Starco Brands Inc. (STCB), closed Friday's trading session at $0.09, up 0.3344482%, on 144,882 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $6.85/$.

Recent News

FuelPositive Corp. (TSX.V: NHHH) (OTC: NHHHF)

The QualityStocks Daily Newsletter would like to spotlight FuelPositive Corp. (NHHHF).

China has turned its massive manufacturing might toward clean energy over the past decade, and the results have been impressive. The east Asian nation produces nearly all the photovoltaic solar panels on the globe, produces the cheapest battery electric cars, and has installed more green-energy infrastructure than any other nation on the globe. Despite the historic tension between the West and China, Western nations could learn a lot from China's rise in the renewable-energy space. While China has spent at least a decade and invested considerable funds toward developing its green industries, the West is largely playing catch up and is almost fully reliant on Chinese companies in the renewables supply chain. Furthermore, EV pilot programs limited the adoption of copycat development procedures in different regions to eliminate duplication, safeguard the quality of products and minimize waste. Rather than leave publicly traded entities such as FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) to play a leading role in growing the clean-energy space, governments need to take deliberate steps aimed at propelling the industry forward so that the private sector complements these efforts. China has done it; the West can do it too.

FuelPositive Corp. (TSX.V: NHHH) (OTC: NHHHF) is a growth stage company focused on licensing, partnership and acquisition opportunities building upon various technological achievements. The company is committed to providing commercially viable and sustainable clean energy solutions, including carbon-free ammonia (NH3), for use across a broad spectrum of industries and applications.

FuelPositive is headquartered in Toronto, Canada.

Hydrogen Economy Problems and FuelPositive’s Carbon-Free Technology

The hydrogen economy is currently facing many challenges. Traditional NH3 manufacturing exists on a massive scale, but centralized facilities result in some of the world’s most concentrated CO2 emissions. In total, an estimated 200 million metric tonnes of NH3 are consumed each year, with greater than 80% utilized by the agricultural sector. NH3 is also being positioned as a viable alternative to fossil fuels.

FuelPositive’s flagship carbon-free ammonia technology provides an innovative solution to these environmental concerns. Developed by Dr. Ibrahim Dincer and his team, the company’s platform allows for the in-situ production of NH3 in an entirely sustainable manner, using only water, air and sustainable electricity.

The production of hydrogen is energy intensive, but it is just one variable hindering the growth of the hydrogen economy. Other hurdles include:

  • Storage – The storage of hydrogen by compression or liquification are both cost prohibitive and unsustainable.
  • Distribution – The distribution network for effective hydrogen deployment has yet to be developed, as the extreme high-pressure distribution requirements to transport hydrogen would result in enormous infrastructure costs.
  • End Use – R&D on the transportation-related end use applications for hydrogen is in its infancy, but almost any vehicle on the road today can be easily converted to run on NH3 at a considerably lower cost per mile traveled when compared to traditional fossil fuels.

A key benefit of FuelPositive’s patent-pending, first-of-its-kind carbon-free NH3 technology is its flexibility. The process allows for small, medium or large-scale production of NH3 on location, minimizing or even eliminating the challenges and volatility associated with storage and transportation to end use. As such, with an appropriately sized FuelPositive system and access to renewable energy, the end use applications for the company’s platform are nearly infinite.

Manufacturing Partnership

On May 19, 2021, FuelPositive announced its selection of National Compressed Air Canada Ltd. (“NCA”) to undertake manufacturing of the company’s Phase 2 hydrogen-ammonia synthesizer commercial prototype systems for carbon-free ammonia production.

In a news release detailing the partnership, FuelPositive CEO Ian Clifford noted, “This critical milestone for FuelPositive will confirm the broad application potential for our technology and is the backbone of our Carbon-Free Hydrogen-NH3 offering. Partnering with the knowledgeable and experienced team at NCA on this commercialization project will bring our development-stage program to life.”

Global Ammonia Market Outlook

The global ammonia market was valued at $52.71 billion in 2017 and is forecast to reach $81.42 billion by 2025, growing at a CAGR of 5.59%, according to data from Fior Markets (https://ibn.fm/1OfOB).

The agricultural industry consumes more than 80% of global NH3. Smaller percentages can be attributed to the waste, water treatment, refrigerants, antiseptic, textile, mining and pharmaceutical industries.

One of the most polluting industries on the planet consists of conventional agribusinesses. These polluters are responsible for more greenhouse emissions per year than transportation. This is where FuelPositive’s technology is expected to be extremely beneficial.

Management Team

Ian Clifford is Director, CEO and Founder of FuelPositive Corp. He has over 25 years of experience in the fields of technology and marketing and has successfully led the company to global brand recognition through its unique energy solutions. Since 2006, Mr. Clifford has raised over $50 million in equity financing for FuelPositive. He also co-founded digIT Interactive, a full-service internet marketing company serving Fortune 500 clients, which he sold at the peak of the market in 2000.

Greg Gooch serves as a Director and President of FuelPositive. His multifaceted career in the electronics and finance industries has positioned him as a key advisor and funding partner to start-ups and new technology companies for over 40 years. Mr. Gooch has been involved with FuelPositive since its early days and has remained a significant supporter and consultant to the company over the years. He has a bachelor’s from McGill University and an MBA from the University of Western Ontario.

Dr. Ibrahim Dincer is a scientific advisor to FuelPositive and is recognized as a pioneer and international leader in the area of sustainable energy technologies. Along with his team, Dr. Dincer invented the modular carbon-free ammonia (NH3) production technology that FuelPositive is commercializing. His area of specialty covers various topics including ammonia, hydrogen energy and fuel cells; renewable energy systems; energy storage systems and applications; carbon capturing technologies, and integrated and hybrid energy systems He is currently managing an exemplary team of researchers in this commercialization project.

Marek Warunkiewicz is the company’s Communications & Branding Specialist. He brings more than 40 years of entrepreneurial expertise to the FuelPositive team, having held marketing, branding, advertising, project management and graphic design positions with various companies. Mr. Warunkiewicz has successfully created business-to-business marketing and advertising campaigns for a diverse group of clients ranging from high-tech to agriculture. He co-founded digIT Interactive and ZENN Motor Company alongside Ian Clifford.

Luna Clifford is the Director of Communications for FuelPositive. She has over 10 years of experience as a business owner and advisor, helping build and operate several successful start-up enterprises while managing complex stakeholder relationships. Ms. Clifford excels in strategic planning and team building, and she has completed extensive studies in the fields of communications and health care.

FuelPositive Corp. (NHHHF), closed Friday's trading session at $0.035, up 6.0606%, on 41,201 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0258/$0.07.

Recent News

Life Electric Vehicles Holdings Inc. (OTC: LFEV)

The QualityStocks Daily Newsletter would like to spotlightFathom Life Electric Vehicles Holdings Inc. (OTC: LFEV) .

A U.S. electric vehicle charging company is developing new technology to deal with EV ‘charging hogs' who let their electric cars linger at public chargers. Two of the many issues that dampen the electric vehicle charging experience are long lines and extended wait times. In many cases, these wait times are caused by drivers who linger at public EV chargers to let their EVs charge to 100%. Unlike fossil fuel-powered cars, which can receive a full tank of gas with no issue, electric car batteries function optimally at 20–80%. "Filling up" your EV regularly (charging up to 100%) can speed up the battery's rate of degradation and reduce its lifespan. Consequently, charging to 80% kills two birds with one stone by aiding in the preservation of EV batteries and improving overall charging experiences for all drivers. Charging has been one of the largest barriers to EV adoption since Tesla first launched the Roadster well over a decade ago. America's network of chargers isn't large enough to support the current number of electric cars on the road, let alone a countrywide fleet of battery electric vehicles (BEVs). Furthermore, issues such as unreliable chargers and long wait lines mean that drivers with access to public chargers typically have poor charging experiences.

The advent of micromobility solutions from enterprises such as Life Electric Vehicles Holdings Inc. (OTC: LFEV) also provides another angle to the charging hogs dilemma. With their smaller batteries, lighter EVs often need a shorter duration at charging points before they have sufficiently topped up and continued on their way.

Life Electric Vehicles Holdings Inc. (OTC: LFEV) (d/b/a Life EV Group), along with its subsidiaries, is a developer, manufacturer and distributor in the light electric vehicle industry. The company’s business model focuses on the launch, acquisition and consolidation of multiple brands of e-bikes, e-trikes, e-scooters and light EVs with the aim of positioning itself as an industry leader for the American micro-mobility market.

The light electric vehicle industry, mainly e-bikes, is fast becoming a leading form of EV sales in the U.S. and Europe. In addition to offering ready-to-ride electric vehicles, Life EV Group intends to distribute individual components, including motors, batteries, chargers, controllers and EV parts, to third party manufacturers in both the U.S. and worldwide.

The company’s first acquisition was completed in 2023 with a 40% equity stake in LEV Manufacturing Inc., a related company and American manufacturer of e-bikes. LEV Manufacturing’s assembly utilizes free-trade zone processes with a U.S. Certificate of Origin, eliminating middle layer costs and resulting in cost-effective production and lower MSRPs.

LEV Manufacturing recently completed the acquisition of Serial 1 Cycle Company LLC. Serial 1 is an e-bike maker founded by U.S. motorcycle manufacturer Harley-Davidson in 2018 and spun off as an independent brand in 2020. The acquisition positions Serial 1 for even greater success and long-term growth.

Life EV Group is headquartered in Deerfield Beach, Florida.

Market Opportunity

An analysis from Mordor Intelligence, a market research and advisory firm, estimates the e-bike market to be worth $34.98 billion in 2024 and projects it will expand to reach a value of $51.78 billion by 2029, representing a CAGR of 8.16% during the forecast period.

Mordor attributes forecast market growth primarily to the increasing adoption of electric bikes as a mode of daily transportation around the world. The market is seeing an upsurge in unit sales based on their attractive consumer characteristics, including health benefits, affordability and convenience.

The North American electric bike market is growing as the preference for low-speed two- and three-wheelers has increased in recent years. Various bike-sharing operators are including electric bikes in their fleets, which is expected to support the sales growth of these bikes in the near future.

Management Team

Robert Provost is the CEO of Life EV Group. He was Founder and CEO of Prodeco Technologies, a maker of e-bikes and e-bike parts and accessories. He also serves as President and CEO of LEV Manufacturing Inc. He is Chairman of the board for Serial 1 Cycle Company.

Daniel Del Aguila is COO at Life EV Group. He co-founded Prodeco Technologies and serves as COO of LEV Manufacturing Inc.

Ivan Drusc is CFO at Life EV Group. He is a seasoned accounting and finance professional with a proven track record in industries from insurance to IT and property management. He has served as a key player in businesses ranging in size from startups to publicly traded global companies. He has experience in cost reduction, risk mitigation, IT and ERP systems, outsourcing and restructuring. He is a graduate of the University of Akron with a bachelor’s degree in accounting.

Life Electric Vehicles Holdings Inc. (OTC: LFEV), closed Friday's trading session at $0.45, even for the day. The average volume for the last 3 months is and the stock's 52-week low/high is $0.3503/$1.25.

Recent News

Platinum Group Metals Ltd. (TSX: PTM) (NYSE American: PLG)

The QualityStocks Daily Newsletter would like to spotlight Platinum Group Metals Ltd. (TSX: PTM) (NYSE American: PLG).

Operator of flagship Waterberg PGM Project located in South Africa, which is home to 70% of platinum and 35% of palladium global mine production in 2023

Over $89M invested to date in exploration and feasibility engineering since initial discovery in 2011

The Waterberg Project has proven and estimated reserves of 19.5 million ounces of PGMs and gold with a projected production life of 45 years

Partnered with major integrated PGM producer Impala Platinum Holdings Ltd. and Japanese consortium HJ Platinum, which includes trading house Hanwa Co. and the government-backed Japan Organization for Metals and Energy Security

A 2019 Definitive Feasibility Study ("DFS") confirmed Waterberg as one of the largest and lowest cost undeveloped PGM projects globally

In December 2023, entered an agreement with Ajlan & Bros Mining and Metals to study establishment of a PGM smelter and base metals refinery in Saudi Arabia

PGM market dynamics are favorable based on growing demand from gasoline hybrid and plug-in hybrid ("PHEV") technology adoption and expected supply cutbacks from major producers in Southern Africa, North America and Russia

An update to the 2019 Waterberg Definitive Feasibility Study is expected in 2024

Founded Lion Battery Technologies Inc. in partnership with Anglo American Platinum Ltd. (AMS: JSE) to research and commercialize the use of PGMs in lithium-sulfur battery chemistry

Platinum Group Metals (NYSE American: PLG) (TSX: PTM) is the operator of the Waterberg Project, a bulk underground platinum group metals ("PGM") deposit discovered by Platinum Group in 2011 and located on the Northern Limb of the Bushveld Complex in South Africa. The Waterberg Project is planned as a fully mechanized platinum, palladium, rhodium and gold mine, including by-product copper and nickel production, and is projected to be one of the largest and lowest cost PGM mines globally.

Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) is the operator of the Waterberg Project, a bulk underground platinum group metals (PGM) deposit discovered by Platinum Group in 2011 and located on the Northern Limb of the Bushveld Complex in South Africa. The Waterberg Project is planned as a fully mechanised platinum, palladium, rhodium and gold mine, including by-product copper and nickel production, and is projected to be one of the largest and lowest cost PGM mines globally.

The project is a joint venture between Platinum Group; integrated PGM producer Impala Platinum Holdings Ltd. (OTCQX: IMPUY); Japanese consortium HJ Platinum, which includes trading house Hanwa Co. and the government-backed Japan Organization for Metals and Energy Security (JOGMEC); and local empowerment partner Mnombo Wethu Consultants (Pty) Ltd. Platinum Group has an effective 50.22% interest in the Waterberg Project.

The company’s primary business objective is to advance the Waterberg Project to a development and construction decision. An update to the 2019 Definite Feasibility Study is expected in 2024.

PGMs are essential and precious metals that include platinum, palladium, rhodium, iridium, osmium and ruthenium. These metals are known for their purity, high melting points and unique catalytic properties. They are utilized in a number of industrial processes, technologies and commercial applications and play a critical role in autocatalysis and pollution control in the automotive sector. The bulk of global PGMs are mined in Southern Africa and Russia.

The unique properties of PGMs are being applied to various technologies as possible solutions for more efficient energy generation and storage, which may create new demand for PGMs. The company’s battery technology initiative through Lion Battery Technologies Inc., using platinum and palladium in lithium battery technologies, represents one such new opportunity in the high-profile lithium battery research and innovation field.

Platinum Group Metals Ltd. founded Lion Battery Technologies Inc. in partnership with Anglo American Platinum Ltd. (AMS: JNB) to support the use of palladium and platinum in lithium battery applications. Lion Battery has entered into an agreement with Florida International University to further advance a research program that uses platinum and palladium to unlock the potential of Lithium Sulfur (Li-S) battery chemistries.

Platinum Group is headquartered in Vancouver, B.C., and Johannesburg, South Africa.

Waterberg Project

Platinum Group’s sole material mineral property, the Waterberg Project, is presently in process with pre-construction permitting; engineering work, including road upgrade and traffic studies; finalization of power and water infrastructure design; and construction camp design.

The company’s principal product from the Waterberg Project is planned to be a PGM-bearing concentrate. The concentrate will contain economic amounts of six elements comprising platinum, palladium, rhodium, gold, copper and nickel. The company’s partner in the Waterberg Project, Impala Platinum Holdings, has acquired a right of first refusal to enter into an offtake agreement, on commercial arm’s-length terms, for the smelting and refining of mineral products from the Waterberg Project.

The Waterberg project has proven and estimated reserves of 19.5 million ounces of PGMs and gold. When fully operational, the mine is projected to produce more than 400,000 ounces of PGMs annually during the peak period of steady state production. The life of the mine is projected at 45 years.

South Africa’s PGM mining sector remains closely tied to economic developments in the global automotive industry, which in 2022 accounted for approximately 43% of the total global demand for platinum and 82% of the total global demand for palladium.

Market Opportunity

According to a report from Straits Research, a global market and business research firm, the worldwide platinum market had an estimated value of $7.72 billion in 2022 and is projected to reach $11.95 billion by 2031. That represents a CAGR of 5.13% over the forecast period.

Platinum, one of the rarest of precious metals, is about 30 times scarcer than gold. It is crucial to the automotive and electronics industries and is also used to make jewelry. Stricter emissions regulations around the world have led to an increased demand for platinum to be used in catalytic converters to reduce automotive emission, the report states.

A report from Allied Market Research estimated the global palladium market at $16.3 billion in 2021 and projects the market will reach $28.6 billion by 2031, growing at a CAGR of 5.8% over the period.

Palladium is also used in automotive catalytic converters for reducing emissions and in jewelry, dentistry, watchmaking, blood sugar test strips, aircraft spark plugs, surgical instruments, electrical contacts and musical instruments.

An increase in demand for consumer electronics has driven demand for palladium-based multilayer ceramic capacitors (MLCC) used to store energy in electronic devices such as broadcasting equipment, mobile telephones, computers, electronic lighting and high voltage circuits, according to the report.

Management Team

Frank R. Hallam is Co-Founder, Director, President and CEO of Platinum Group. He has over 30 years of experience in the mining, minerals and petroleum industry as an operator, principal and founder. He was a co-founder and former CFO of MAG Silver Corp. He was also co-founder and director of West Timmins Mining Inc. and a director of Lake Shore Gold Corp. In addition, he was CFO and director with gold exploration company Tan Range Exploration Corp. He is a Chartered Professional Accountant and was formerly an auditor in the public mining practice of PwC. He holds a Bachelor of Business Administration from Simon Fraser University.

Greg Blair is CFO of Platinum Group. He has been with Platinum Group since 2010 in various roles, most recently as Interim CFO. Prior to joining Platinum Group, he was at a public accounting firm working on public company (mainly mining) audits. He is a Chartered Professional Accountant and holds a degree in Economics from Simon Fraser University and has completed the Canadian Securities Course.

Kris Begic is VP Corporate Development of Platinum Group. He has over 25 years of experience in the mining industry and capital markets and has been involved with the raising of over $500 million for various exploration and development projects globally. His efforts are focused on project generation, mergers and acquisitions, capital markets, investor relations and marketing.

Platinum Group Metals Ltd. (NYSE American: PLG), closed Friday's trading session at $1.35, off by 0.7352941%, on 165,569 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.942/$2.07.

Recent News

D-Wave Quantum Inc. (NYSE: QBTS)

The QualityStocks Daily Newsletter would like to spotlight D-Wave Quantum Inc. (NYSE: QBTS).

Expanded product roadmap to enhance D-Wave's Leap(TM) quantum cloud service and bring new Quantum AI solutions to market

Initiative targets three key development areas: quantum distributions for generative AI, Restricted Boltzmann Machine ("RBM") architectures, and GPU integration

CEO Dr. Alan Baratz emphasizes the potential of annealing quantum computing to transform AI/ML by offering more efficient model training, reduced energy consumption, and faster time-to-solution

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services, and the first commercial provider of quantum computers, has announced a significant expansion of its Leap quantum cloud service, targeting advancements in artificial intelligence ("AI") and machine learning ("ML"). The newly revealed roadmap outlines strategic initiatives aimed at integrating quantum computing with AI/ML technologies to offer more efficient and powerful computational capabilities (https://ibn.fm/oZpfR).

D-Wave Quantum Inc. (NYSE: QBTS) ("D-Wave"), a leader in quantum computing systems, software and services, and the world's first commercial supplier of quantum computers, is featured in a NetworkNewsAudio ("NNA") broadcast. NNA broadcasts are designed to provide additional visibility, recognition and brand awareness to the investment community. According to the broadcast, D-Wave is focused on strengthening the connection between quantum optimization, artificial intelligence (AI) and machine learning (ML). The company is working to accomplish this by extending its product development roadmap with enhancements to its Leap™ quantum cloud service.

Three key areas are included in D-Wave's product development roadmap extensions: quantum distributions for generative AI, Restricted Boltzmann Machine (RBM) architectures, and graphic processing unit (GPU) integration with the Leap quantum cloud service.

"We're seeing early evidence that annealing quantum computing could play a key role in helping AI/ML with more efficient model training, reduced energy consumption and faster time-to-solution," said D-Wave CEO Dr. Alan Baratz in the press release. "With results demonstrating our annealing quantum computer's ability to outperform classical techniques, coupled with rapidly increasing demand from our customers for Quantum AI solutions that integrate with their business optimization requirements, we believe the impact of D-Wave's Quantum AI solutions could be transformative, bringing a powerful set of new computing tools for generative AI."

To hear the broadcast, visit: https://ibn.fm/WpM6P

To view the full press release, visit https://ibn.fm/KrqtL

D-Wave Quantum Inc. (NYSE: QBTS) is a leader in quantum computing systems, software and services focused on delivering customer value via practical quantum applications for problems such as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection and financial modeling. As the only provider building both annealing and gate-model quantum computers, the company is unlocking commercial use cases in optimization today, while building the technologies that will enable new solutions tomorrow.

D-Wave is a pioneer in quantum computing, with a history of delivering the world’s first commercial quantum computer; the first real-time quantum cloud service; countless hardware and software product and research milestones; and the planned first cross-platform quantum solution which will deliver both annealing and gate-model quantum computers to customers via an integrated platform. Its current commercial product offerings include: Advantage™ (fifth generation quantum computer), Leap™ (quantum cloud service), Launch™ (quantum computing onboarding service) and Ocean™ (full suite of open-source programming tools).

D-Wave’s relentless pursuit of practical quantum computing has resulted in the technology being used today by some of the world’s most advanced enterprises – more than 25 of the Forbes Global 2000 use D-Wave.

D-Wave’s commercial customers include blue-chip industry leaders like Volkswagen, Accenture, BBVA, NEC Corporation, Save-On-Foods, DENSO and Lockheed Martin. The company boasts an extensive IP portfolio featuring more than 200 issued U.S. patents and over 100 peer-reviewed papers published in leading scientific journals.

Founded in 1999, D-Wave is the world’s first commercial supplier of quantum computers. With headquarters and the Quantum Engineering Center of Excellence based near Vancouver, Canada, D-Wave’s U.S. operations are based in Palo Alto, California.

Advantage™ Quantum Computer

 

With the Advantage™ Quantum Computer, D-Wave has incorporated two decades of experience and over 10 years of customer feedback to create the first and only quantum computer designed for business. The platform features a new processor architecture with over 5,000 qubits and 15-way qubit connectivity. This is 2.5x more connections and more than double the number of qubits than the company’s previous generation quantum computer.

D-Wave’s quantum computers, first located in its facilities in British Columbia, have been available to North American users through its Leap™ quantum cloud service since 2018. It has since introduced new Advantage systems in Julich, Germany, and most recently, Marina Del Rey, California, which marked the availability of the first Advantage quantum computer physically located in the United States.

That new deployment is part of the USC-Lockheed Martin Quantum Computing Center (QCC) hosted at USC’s Information Sciences Institute (ISI), a unit of the University of Southern California’s prestigious Viterbi School of Engineering. Additionally, Amazon Web Services (AWS) and D-Wave announced that the U.S.-based system is available for use in Amazon 2racket, expanding the number to three different D-Wave quantum systems available to AWS users.

Leap Quantum Cloud Service

 

D-Wave’s customers interface with its systems through the Leap™ quantum cloud service. Leap delivers immediate, real-time access to the company’s Advantage quantum computer and quantum hybrid solver service, all with enterprise-class performance and scalability.

Leap allows developers proficient in Python to get started building and running quantum applications. Through a seamless and secure cloud-based connection, users can easily start solving complex problems of up to 1 million variables and 100,000 constraints.

Using Leap, D-Wave customers have developed quantum hybrid applications for use cases in manufacturing, logistics, financial services, life sciences, materials science, retail and transportation. By eliminating the need to wait hours, days or weeks to get good answers to a broad array of problems, D-Wave is helping businesses move forward.

D-Wave Launch

D-Wave Launch™ is the company’s onboarding platform aimed at helping businesses easily start their quantum journey. Through this program, D-Wave’s team of experts and partners aid enterprises in identifying best use cases for quantum and work with them to develop a proof of concept and production pilot.

From there, the team coordinates with customers to get their hybrid quantum applications up and running, providing ongoing Leap quantum cloud access to ensure the application is operating smoothly and delivering real business value.

Target Verticals

While the potential applications for quantum computing are effectively limitless, D-Wave has identified a number of industry verticals as key areas of focus for its quantum architecture, providing case studies for each. These include:

  • Manufacturing – D-Wave worked with Volkswagen to identify a commercial optimization application, the binary paint shop problem, which was run on D-Wave’s hybrid solver service. The solver outperformed four purely classical methods on problem sizes at commercial scale (N=3,000). In a separate project, similar inputs were tested using a leading ion trap system, which failed to find any commercial solution.
  • Life Sciences – Menten AI makes use of D-Wave quantum computing to assist in the design of novel therapeutic peptides—short strings of amino acids that can act as potent drugs. With the rise of COVID-19, D-Wave’s Advantage system made it possible to identify molecules that might be especially well-suited for binding and inhibiting the related spike protein, producing several promising peptide designs.
  • Finance – Multiverse Computing, a leader in developing quantum solutions for the financial sector, leveraged D-Wave’s hybrid solver service in a collaboration with BBVA, one of the world’s largest financial institutions. Multiverse demonstrated management strategies that far exceeded the granularity of traditional returns in a fraction of the time, helping BBVA identify a low-risk portfolio for investment.

Market Opportunity

The quantum computing total addressable market is projected to grow between $450 billion and $850 billion over the next 15 to 30 years, with between $5 billion and $10 billion of anticipated TAM growth coming in the next three to five years, according to Boston Consulting Group. Driving factors behind this growth include rising investments in quantum computing tech by governments and an increasing number of commercial use-cases.

Forward-thinking organizations see quantum as an opportunity to move ahead of the competition. From finding efficiencies and reducing waste to decreasing time to solution and solving problems abandoned due to complexity, the business value is real. According to data from 451 Research, 40% of large enterprises are already experimenting with quantum computing.

D-Wave is strategically positioned – in an industry with significant barriers to entry – as evident by a decades-long track record serving a roster of blue-chip customers. The company is singularly focused on helping its customers achieve clear value by leveraging quantum computing in practical business applications. With a full stack of systems, software, developer tools and services, D-Wave is working to enable enterprises, governments, developers and researchers to access the power of quantum computing, thereby providing an intriguing opportunity for prospective investors.

D-Wave’s current investor base includes PSP Investments, Goldman Sachs, BDC Capital, NEC Corporation, Aegis Group Partners and In-Q-Tel.

Leadership Team

Dr. Alan Baratz has served as the CEO of D-Wave since 2020. Previously, as Executive Vice President of R&D and Chief Product Officer, he drove the development, delivery, and support of all of D-Wave’s products, technologies, and applications. Dr. Baratz has over 25 years of experience in product development and bringing new products to market at leading technology companies and software startups. As the first president of JavaSoft at Sun Microsystems, he oversaw the growth and adoption of the Java platform from its infancy to a robust platform supporting mission-critical applications in nearly 80 percent of Fortune 1000 companies. He has also held executive positions at Symphony, Avaya, Cisco, and IBM. Dr. Baratz holds a doctorate in computer science from the Massachusetts Institute of Technology.

John Markovich is the company’s CFO. He brings to D-Wave over three decades of experience working with rapidly growing private and public technology companies across all stages of development. Mr. Markovich has directed the finance, accounting, tax, treasury, M&A, legal, operations, customer service, IR, HR, and IT functions for companies ranging from privately held pre-revenue startups to an NYSE-listed Fortune 500 multi-national company with over $1.2 billion in annual revenue. During his career, he has negotiated and closed over 150 debt, equity, M&A, and joint venture transactions exceeding $2.5 billion in value; over a dozen private placements; nearly a dozen M&A transactions; and several international joint ventures. Mr. Markovich holds a BS in Business from Miami University and an MBA from the Michigan State Graduate School of Business.

D-Wave Quantum Inc. (NYSE: QBTS), closed Friday's trading session at $0.9299, off by 0.9796614%, on 1,780,155 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.57/$2.44.

Recent News

Correlate Energy Corp. (OTCQB: CIPI)

The QualityStocks Daily Newsletter would like to spotlight Correlate Energy Corp. (OTCQB: CIPI).

Correlate (OTCQB: CIPI), a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America, is driving scalability in the microgrid energy distribution market. This follows a new partnership between its subsidiary Distributed Energy Capital ("DEC") and clean energy development innovator Compass Energy that will establish the United States' first microgrid utility. "The landmark initiative by Distributed Energy Capital and Compass Energy Platform to adopt renewable utility infrastructure is for Ohio's Cuyahoga County. The county formed Cuyahoga Green Energy (‘CGE') three years ago as a utility focused entirely on renewable energy and resiliency. CGE's project differs from traditional microgrids in that it will provide power to multiple interconnected customers, including commercial, industrial, and later, government and community loads," a recent article reads. "This initiative addresses a significant problem by providing resilient energy solutions for this county and opens up tremendous opportunities for our company to meet similar needs across North America," said Correlate Energy CEO Todd Michaels.

To view the full article, visit https://ibn.fm/9HdtW

Correlate Energy Corp. (OTCQB: CIPI) is a publicly-traded company strategically positioned to capitalize on America’s unstoppable trend toward decentralized energy generation.

The energy grid in the U.S. is insufficient for the booming clean energy trend, and current infrastructure is limiting green energy distribution. Constructing the needed infrastructure to address this demand imbalance will cost billions and be far too slow, positioning decentralized systems, like those on offer from Correlate, in a key position for heightened demand.

Correlate has identified several key economic drivers powering the decentralized energy trend, including:

  1. Real Cost Savings – Customer pays zero money down and gets an instant electrical price discount to current rates.
  2. Massive Project Investment Funding – The International Energy Agency estimates that over one billion dollars per day will be invested in solar energy in 2023.
  3. Consistent Long-Term Incentives – The Inflation Reduction Act is a game-changer, supercharging renewables with $1.2 trillion in tax credits for 10 years of market support.
  4. Robust Customer Demand – Wood Mackenzie expects the U.S. solar industry to nearly triple in size over the next five years.

Correlate’s team of multi-decade experts who have worked with renowned global brands are positioning the company to make the most of this opportunity while consolidating a fragmented industry. Collectively, the team has developed, financed and deployed over $2 billion in clean energy projects to date.

Three-Pronged Strategy

Correlate is leveraging a three-pronged strategy aimed at driving shareholder value:

  1. Sell – Correlate seeks to finance, develop and profitably sell localized clean energy solutions and microgrids to industrial, commercial and residential customers.
  2. Retain – Correlate plans to retain ownership of some of these energy systems and thereby realize ongoing, reliable cash flow.
  3. Acquire – Correlate seeks to acquire proven renewable energy companies in order to exponentially grow earnings per share for investors.

This strategy is enhanced by current investment trends. Clean energy earnings are being sought after by investors. In Q4 2022, the median EBITDA multiple for green energy companies was 12.3x, according to Finerva.

Market Outlook

Over the next decade and beyond, renewable energy growth is expected to come primarily via decentralized systems like those offered by Correlate.
The Inflation Reduction Act enacted in late August 2022 is likewise expected to drive growth for the company by providing new tax incentives that reduce costs for clients and/or elevate returns to investors.

Commercial buildings consume more than 35% of the generated electricity in the U.S. and are underperforming in energy efficiency at every level. These buildings waste energy, emit too much carbon and are too costly for owners and occupants, but retrofits are not happening at the rate or scale needed.

In today’s real estate market, portfolio property owners own most commercial buildings, yet most building efficiency work is focused on single buildings, thereby missing the distinct needs of this owner class which are very different from traditional owner-occupiers. The diverse nature of commercial buildings, combined with technology and performance uncertainty, make simple energy optimization initiatives – which could greatly reduce energy use and improve building value – financially unattractive, resulting in slow adoption rates. CIPI’s financial instruments and software breakdown this issue, known as the ‘split incentive’, unlocking the majority of the addressable market.

A key portion of Correlate’s strategy relates to consolidation of what has been a fragmented industry. By uncovering opportunities to improve efficiencies through strategic M&A activities, the company intends to enhance profitability throughout its operations.

Management Team

Todd Michaels is President and CEO of CIPI and founder of Correlate. He formerly served as Vice President for Innovation at SunEdison and Senior Director Distributed Solar at NRG Energy. He founded Correlate in 2015 and has 16 years of experience in the energy industry. He graduated from Indiana University with a B.S. in Computer Information Systems.

Channing Chen is CFO at CIPI and Correlate Inc. and brings over 16 years of experience in the solar industry as a developer, financier, and business unit leader. He has held executive management roles at Solar Power Partners (acquired by NRG Energy), where he was a founding employee, SunEdison, and NRG Energy (NYSE: NRG). Most recently, Mr. Chen was founder and Managing Partner at Breakaway Energy Partners LLC – a distributed energy financing and market-making platform. To date, Mr. Chen and his teams have raised over $1.5 billion in financing across residential, commercial, and utility scale solar and energy storage projects representing over 400 MWs. He holds a B.A. in Environmental Chemistry from the University of California at San Diego and an MBA from the University of Southern California. He is also an advisor and early-stage investor to several startup companies in the renewable energy space.

Dave Bailey is Chief Revenue Officer of Correlate Inc. With over 15 years of executive sales, supply chain management, and energy efficiency experience, he is responsible for ensuring the success of the National Commercial Sales Unit across multiple regional project teams. Mr. Bailey created and launched the Transformation Services team while at Wesco for its multibillion-dollar Distributed Energy Resource division, formerly Westinghouse. His focus was on IoT-enabled efficiency and plant floor automation-based services. Before that, he spent several years in Global Account Sales Management, with GE Supply as a Program Manager, and is a Commercial Leadership Program graduate. Mr. Bailey received his B.S. in Mechanical Engineering from the University of Kentucky.

Jed Freedlander is the company’s Chief Development Officer. He has a background in infrastructure development and investment and a strong legal, commercial and finance acumen. Mr. Freedlander has a proven track record in leading complex public-private partnership (P3) and energy transactions and is instrumental in driving Correlate’s strategic development initiatives.

Roger Baum is Executive VP Operations at Correlate. With over 20 years of experience at Core Construction, he brings to the company a wealth of knowledge and a strong track record in delivering successful commercial construction projects.

Jason Loyet is Director of Solar Energy for Correlate Inc. He is a cleantech executive with over 20 years of experience leading high growth solar energy and software start-ups. Mr. Loyet is a U.S. Department of Energy SunShot Catalyst award winner for his work building the Solar Site Design technology platform. Before joining the solar energy industry in 2005, he founded and sold two software companies in the streaming media (GlobalStreams) and newspaper publishing (MyCapture) industries. Mr. Loyet currently serves as a Member of the Board of Directors for the Tennessee Solar Energy Industry Association (TenneSEIA).

Correlate Energy Corp. (OTCQB: CIPI), closed Friday's trading session at $0.1551, off by 39.4826%, on 500 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.05/$2.35.

Recent News

InMed Pharmaceuticals Inc. (NASDAQ: INM)

The QualityStocks Daily Newsletter would like to spotlight InMed Pharmaceuticals Inc. (NASDAQ: INM).

InMed Pharmaceuticals (NASDAQ: INM), a clinical stage company developing a pipeline of pharmaceutical drug candidates to treat several diseases with a high unmet medical need, is at the forefront of developing innovative treatment for age-related macular degeneration ("AMD"), with its flagship product INM-089 showing great promise. "AMD is a prevalent eye condition that primarily affects older adults, leading to vision loss in the central part of the retina, known as the macula… AMD is the leading cause of vision loss among people aged 50 and older. It comes in two forms: dry AMD, which is more common and less severe, and wet AMD, which is rarer but more severe," a recent article reads. "Results from several in vitro and in vivo studies demonstrated several pharmacological effects in the potential treatment of dry AMD. These include: providing neuroprotection of photoreceptors and improving photoreceptor function; preserving retinal function in the back of the eye; improving integrity of the retinal pigment epithelium (‘RPE'); and improving the thickness of ‘outer nuclear layer' (‘ONL') of the retina where photoreceptors are located."

To view the full article, visit https://ibn.fm/Bggvj

InMed Pharmaceuticals Inc. (NASDAQ: INM) is a global leader in the manufacturing and clinical development of rare cannabinoids. InMed is a clinical stage company developing cannabinoid-based pharmaceutical drug candidates, as well as manufacturing technologies for pharmaceutical-grade rare cannabinoids.

The company is dedicated to delivering new therapeutic alternatives to treat conditions with high unmet medical needs. The company is also developing a proprietary manufacturing technology to produce pharmaceutical-grade rare cannabinoids in the lab and has recently announced an LOI to acquire a leading rare cannabinoid manufacturer.

Research and Technology

There are more than 100 rare cannabinoids found in only trace amounts in the cannabis plant, together making up less than 1% of the plant’s biomass. InMed is initially focused on the therapeutic benefits of cannabinol (CBN) in diseases with high unmet medical need. Preclinical studies of CBN demonstrated an excellent safety profile and showed CBN has potential for therapeutic benefit over other cannabinoids such as tetrahydrocannabinol (THC) and cannabidiol (CBD).

Evidence suggests there may be great therapeutic potential in rare cannabinoids. Each has a specific chemical structure, and different cannabinoids have been observed to have distinct physiological properties in humans, including therapeutic potential for specific diseases as well as unique safety profiles. CBN is the active pharmaceutical ingredient (API) in InMed’s two lead programs for dermatological and ocular diseases.

InMed’s most advanced compound, INM-755, is a CBN topical cream under clinical development for the treatment of epidermolysis bullosa, a severe genetic skin disorder. To date, INM-755 has been evaluated in two Phase 1 clinical trials in healthy volunteers. InMed has filed Clinical Trial Applications in several countries as part of a global Phase 2 clinical trial of INM-755 (cannabinol) cream in epidermolysis bullosa. Responses from the National Competent Authorities and Ethics Committees are expected throughout the summer of 2021.

InMed is also involved in developing INM-088, an ocular CBN formulation being researched for the treatment of glaucoma, the second leading cause of blindness in the developed world. InMed is currently evaluating several formulations to deliver CBN into the eye to address issues of dosing frequency, side effects and treatment penetration. INM-088 is being designed for topical delivery to the eye. This localized delivery results in very little drug being absorbed or migrating into the bloodstream, thus minimizing potential adverse side effects. INM-088 shows promise to reduce intraocular pressure and provide neuroprotection of the eye.

Manufacturing

The limited availability of rare cannabinoids like CBN makes them economically impractical to extract directly from the plant for pharmaceutical use. InMed is developing IntegraSyn, a cannabinoid synthesis manufacturing system to create rare cannabinoids in the lab that are bioidentical to the compounds derived from the cannabis plant. IntegraSyn uses multiple standard pharmaceutical processes and has achieved a cannabinoid yield of 5 grams per liter, surpassing commercial viability and significantly exceeding currently reported industry yields. InMed is now focusing on manufacturing scale-up to larger batch sizes while continuing process optimization, targeting increased cannabinoid yield and further reducing overall cost of goods.

BayMedica Inc. Acquisition

On June 29, 2021, InMed announced it had entered into a non-binding letter of intent to acquire BayMedica Inc., a private company based in Nevada and California that specializes in the manufacture and commercialization of rare cannabinoids.

As noted in the news release, BayMedica is a revenue-stage biotechnology company leveraging its significant expertise in synthetic biology and pharmaceutical chemistry to develop efficient, scalable and proprietary manufacturing approaches to produce high quality, regulatory-compliant rare cannabinoids for consumer applications. BayMedica is currently commercializing the rare cannabinoid CBC (cannabichromene) as a B2B supplier to distributors and manufacturers marketing products in the health and wellness sector. BayMedica is planning additional rare cannabinoid launches for the coming year.

Pursuant to the indicative terms of the LOI, InMed and BayMedica intend to negotiate and enter into a definitive agreement under which InMed would acquire 100% of BayMedica in exchange for 1.6 million InMed common shares to be issued to BayMedica’s equity and convertible debt holders, with any such issued InMed common shares being subject to a six-month contractual hold period.

Market Outlook

There is a rapidly growing demand for rare cannabinoids. However, their low natural concentration makes traditional harvesting of these compounds cost prohibitive. Biosynthesis allows production of rare cannabinoids in the lab that are bioidentical to compounds found in nature, with significantly higher yields which reduce costs. Biosynthesis can produce pharmaceutical-grade, bioidentical, THC-free compounds at a cost that’s 70 to 90 percent less than wholesale prices of naturally harvested rare cannabinoids.

Cannabinoid-based pharmaceuticals are expected to overtake the market as rare cannabinoids become less expensive and more available. According to Statista, the value of the consumer market for cannabinoid-based pharmaceuticals in the United States is forecast to grow to $25 billion by 2025 and to $50 billion by 2029, with cannabinoid-based pharmaceuticals used to treat health conditions including pain, respiratory conditions, autoimmune conditions and more.

Management Team

Eric A. Adams has been CEO and president of InMed since June 2016. He has more than 25 years of experience in establishing corporate entities, capital formation, global market development, mergers and acquisitions, licensing and corporate governance. He previously served as CEO at enGene Inc. Prior to enGene, he held senior positions in global market development with QLT Inc. (Vancouver), Advanced Tissue Sciences Inc. (La Jolla, CA), Abbott Laboratories (Chicago, IL) and Fresenius AG (Germany).

Bruce S. Colwill is InMed’s CFO. He has more than 25 years of financial leadership experience in public and private companies. Prior to InMed, he served as CFO of General Fusion Inc., a private clean energy company. He was also CFO at Entrée Resources Inc., a mineral exploration company, from 2011 to 2016. He has held CFO roles at Neuromed Pharmaceuticals Ltd., Response Biomedical Corp, Forbes Medi-Tech Inc. and Euronet Worldwide Inc.

Alexandra D.J. Mancini is Senior Vice President, Clinical and Regulatory Affairs at InMed. She has more than 30 years of global biopharmaceutical research and development experience. She has been an executive with numerous biotech companies, including senior vice president of Clinical and Regulatory Affairs at Sirius Genomics; senior vice president of Clinical and Regulatory Affairs at INEX Pharmaceuticals; and vice president of Regulatory Affairs at QLT Inc.

Eric C. Hsu is Senior Vice President, Pre-Clinical Research and Development at InMed. He joined InMed with more than 18 years of scientific leadership experience in the field of gene therapy. He has held various positions within enGene Inc., including vice president of Research and vice president of Scientific Affairs and Operations. He received his Doctorate from the Department of Medical Biophysics at the University of Toronto.

Michael Woudenberg is Vice President, Chemistry, Manufacturing and Controls at InMed. He has more than 20 years of successful drug development, process engineering, GMP manufacturing and leadership experience. He has held positions with 3M, Cardiome Pharma, Arbutus Biopharma and, most recently, was Managing Director of Phyton Biotech LLC.

InMed Pharmaceuticals Inc. (INM), closed Friday's trading session at $0.1404, off by 2.5%, on 483,805 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.1207/$2.08.

Recent News

Emperor Metals Inc. (CSE: AUOZ) (FRA:9NH) (OTCQB: EMAUF)

The QualityStocks Daily Newsletter would like to spotlight Emperor Metals Inc. (CSE: AUOZ) (FRA:9NH) (OTCQB: EMAUF).

Following a recent surge, the price of gold has shifted, with new data supporting a broader market rally while alleviating concerns about a possible hard landing for the U.S. economy. Last week, bullion for immediate delivery recorded a 1.9% rise, a huge recovery from the almost 3% decrease it recorded during its losing streak. This rebound was observed after the U.S. Department of Labor released data reporting the largest reduction in unemployment benefit applications in almost 12 months. This development has increased optimism that the Central Bank may start easing monetary policy as early as September while steering clear of recession. Helima Croft, an analyst from RBC Capital Markets, noted that the combination of fears of recession, geopolitical risks, anticipated reduction in rates of interest and heightened volatility had driven the price of gold to its current level. The resilience shown by gold during these turbulent market conditions suggests that as exploration companies such as Emperor Metals Inc. (CSE: AUOZ) (OTCQB: EMAUF) (FRA: 9NH) bring new mines into production, the shareholder value delivered is likely to be higher than initially projected.

Emperor Metals Inc. (CSE: AUOZ) (FRA:9NH) (OTCQB: EMAUF) is an advanced stage gold exploration company focused on proving and developing the substantial resource potential of its flagship Duquesne West Gold Project located in the Tier 1 district of the Southern Abitibi Greenstone belt of Rouyn-Noranda, Quebec. The Project has a 2011 historical mineral resource estimate of 727,000 ounces of Au at 5.42 g/t and an average thickness of 5.71 m*.

In 2023, with the use of AI (Artificial Intelligence), Emperor Metals created the first ever 3D mineralized and geological model, which illuminated the potential to add significant ounces to this deposit. Using these models, Emperor’s had a very successful 2023 drilling campaign of 8,579 m. In addition to laterally extending high grade zones by intercepting grades of 15.8 g/t Au over 10.8 meters, Emperor encountered intercepts of lower grade bulk tonnage in the host rocks (1.69 g/t Au over 25 m). This led to envisioning a different strategy of exploration and the revelation that a conceptual open-pit potentially overlies this high-grade gold deposit. Historic core sampling began (2,500 m) for discovering overlooked lower grade gold in the host rock around the high-grade lenses. Lower grade bulk tonnage gold improves the open-pit economics by reducing stripping ratios and adding overlooked incremental ounces for open pit mining.

Emperor Metals is set to begin a fully funded Phase II 8,000 m drilling program in May 2024. The company also plans on assaying an additional 8,000 m of historic core within the open pit model. Emperor is working toward producing an updated NI 43-101 Mineral Resource Estimate by Q1 2025.

The company is led by a dynamic group of resource sector professionals who have a strong record of success in evaluating and advancing mining projects from exploration through to production, attracting capital and overcoming adversity to deliver exceptional shareholder value.

Project

Emperor Metals has an option to earn 100% ownership of the Duquesne West Gold Project, a mineral claim package comprising 38 claims covering approximately 1,389 ha (3,432 acres) in Quebec.

The Duquesne West Gold Property is located 32 kilometers northwest of the city of Rouyn-Noranda and 10 kilometers east of the town of Duparquet. The property lies within the historic Duparquet gold mining camp in the southern portion of the Abitibi Greenstone Belt in the Superior Province.

Emperor is targeting the potential multimillion-ounce resource in a combination of conceptual open pit and underground mining scenarios. A Phase I drill campaign and historical core sampling program was completed in 2023, which included resource confirmation and exploration drilling, focusing on delineating and growing the resource toward development.

The property hosts a historical inferred mineral resource estimate of 727,000 ounces of gold at a grade of 5.42 grams per ton (g/t) and average stope thickness of 5.71 m. The mineral resource estimate predates modern Canadian Institute of Mining guidelines, and a Qualified Person on behalf of Emperor Metals has not reviewed or verified the mineral resource estimate. Therefore, it is considered historical in nature and is reported solely to provide an indication of the magnitude of mineralization that could be present on the property. The gold system remains open for resource identification and expansion.

Reinterpretation of the existing geological model was created using artificial intelligence and machine learning. This AI model shows the opportunity for additional discovery of ounces by revealing gold trends unknown to previous workers and the potential to expand the resource along significant gold-endowed structural zones. Multiple scenarios exist to expand additional resources, which include:

  • Underground High-Grade Gold
  • Open Pit Bulk Tonnage Gold
  • Underground Bulk Tonnage Gold

The Duquesne West-Ottoman property straddles the Porcupine-Destor gold localizing fault several kilometers east of the town of Duparquet. A number of previous drill campaigns have outlined an inferred resource of 4.17 million tons grading 5.42 g/t of gold (cut) or 6.36 g/t (uncut), as reported in the NI 43-101 report titled “Technical Report and Mineral Resource Estimate Update for the Duquesne-Ottoman Property, Quebec, Canada.”

Emperor Metals is funded for an 8,000-meter drilling program focusing primarily on adding ounces to the current resource within and lateral to the open pit model. An additional 8,000 m of historical core sampling and assaying is included in the budget to help build incremental ounces in the open-pit environment.

Market Opportunity

The World Gold Council, the industry association for the world’s gold producers, estimated in 2023 the physical financial gold market, which is made up of bars, coins, gold ETFs and central bank reserves, to be worth nearly $5 trillion.

The council reports that gold mine production adds approximately 3,500 tons of the precious metal to the world’s supply annually, equivalent to about 2% growth. This historical scarcity and relatively slow production of new supply, as compared to other commodities, is a primary reason gold has retained its value for millennia, according to the council.

In May 2024, the market price of gold was approximately $2,340 per ounce.

Management Team

John Florek, P.Geol., is President, CEO and Director of Emperor Metals. He has more than 35 years of technical and senior management experience with major and junior mining companies, including roles as founder, vice president and director. He has helped identify and develop significant asset value for mines and exploration projects from grass roots through development. He has worked for several major mineral producers, including BHP, Placer Dome, Barrick, Teck and Detour Gold/Kirkland Lake Gold/Agnico Eagle.

Sean Mager is CFO and Director of Emperor Metals. He has worked more than 30 years in the mining sector, including extensive experience in corporate development, stakeholder relations, regulatory, financial and operations.

Alex Horsley is Head of Corporate Development and Director of Emperor Metals. He has more than 20 years of experience in the mining sector and capital markets with a focus on finance, marketing, management, corporate development and communications. He is founder and former CEO of Emperor Metals. He has assisted in raising more than C$40 million for exploration and development mining companies.

*Power-Fardy and Breede, 2011. The Mineral Resource Estimate (MRE) constructed in 2011 is considered historical in nature as it was constructed prior to the most recent Canadian Institute of Mining and Metallurgy (CIM) standards (2014) and guidelines (2019) for mineral resources. In addition, the economic factors used to demonstrate reasonable prospects of eventual economic extraction for the MRE have changed since 2011. A qualified person has not done sufficient work to consider the MRE as current. Emperor is not treating the historical MRE as current. The reader is cautioned not to treat it, or any part of it, as a current MRE.

Emperor Metals Inc. (OTCQB: EMAUF), closed Friday's trading session at $0.0737, off by 5.3915%, on 75,370 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.058/$0.14505.

Recent News

HealthLynked Corp. (OTCQB: HLYK)

The QualityStocks Daily Newsletter would like to spotlightFathom HealthLynked Corp. (OTCQB: HLYK) .

HealthLynked (OTCQB: HLYK), a trailblazer in healthcare technology, today announced financial results for its Q2 and H1 2024 ending June 30, 2024. The announcement noted that the company achieved significant cost reductions, leading to an 8% quarter-over-quarter improvement in its loss from operations to $1.08 million in Q2 2024 from $1.18 million in Q1 2024. This improvement reflects HealthLynked's ongoing efforts to streamline operations and transition its revenue streams from legacy clinical operations to app-based services. In addition, the company reported revenue of $0.78 million in Q2 2024 and $1.80 million in H1 2024. Its total operating expenses decreased by 25% in Q2 2024 compared to Q2 2023 and by 24% in H1 2024 compared to H1 2023. The net loss was $1.54 million in Q2 2024 and $2.93 million in H1 2024.

"Our continued focus on cost reduction has been crucial in setting a strong foundation for our transition towards app-based technology services. Additionally, our recent partnerships, which have expanded our telemedicine services nationwide and introduced prescription discounts through RxSpark, are pivotal steps in enhancing our offerings. We believe that these strategic initiatives will unlock significant growth opportunities and lead to better healthcare outcomes for our members."

To view the full press release, visit https://ibn.fm/0UA8B

HealthLynked Corp. (OTCQB: HLYK) is at the forefront of a transformative movement in healthcare, utilizing its extensive collection of health data to improve care for all. With a commitment to leveraging its advanced technology platforms, HealthLynked employs a sophisticated, cloud-based network that serves as a comprehensive repository for personal health data. This system not only simplifies the management and archiving of medical records but also enables the application of AI to deliver personalized healthcare insights. Through deep analysis of this data, HealthLynked’s AI capabilities help identify the root causes of diseases, tailor healthcare solutions to individual needs, and accelerate medical discoveries.

HealthLynked Corp. App

In addition to these capabilities, HealthLynked provides a user-friendly platform for booking healthcare appointments, similar to how OpenTable operates for restaurant reservations. This feature allows patients to conveniently book appointments with healthcare providers across the country, including options for telemedicine consultations, enhancing accessibility and efficiency in healthcare service delivery.

Strategically headquartered in Naples, Florida, HealthLynked operates through three primary divisions: Health Services, Digital Healthcare, and Medical Distribution. Each division supports the company’s mission to revolutionize patient care and health management. Positioned as a potential leader in healthcare AI, HealthLynked is dedicated to shaping the future of the industry over the next 20 years, driving significant advancements in healthcare accessibility and effectiveness through innovation and technology.

HealthLynked Corp. Reach

Strategic Initiatives and Operational Highlights

The company’s commitment to enhancing global health is evident in its dual goals: transforming healthcare through advanced technology and creating a patient-centric network that accelerates medical discoveries and the development of disease cures.

HealthLynked’s intellectual property portfolio is robust and strategically developed to enhance healthcare delivery and management. In March 2023, HealthLynked was granted a patent for a groundbreaking healthcare-specific wireless access point, known as the “Patient Access Hub.” This technology significantly improves the efficiency of healthcare practices by enabling real-time monitoring of patient flow within facilities. It intelligently determines patients waiting in exam rooms and calculates wait times, alongside other critical practice metrics. This system not only enhances patient experience by reducing unnecessary wait times but also optimizes resource allocation within healthcare settings.

Additionally, in October 2023, HealthLynked filed a patent application for its advanced AI program, ARI (Augmented Real-time Interface). ARI acts as a virtual doctor for patients, capable of performing medical intake, booking appointments, and providing personalized medical recommendations based on a patient’s medical history. By integrating these tasks, ARI streamlines the healthcare process, reducing the administrative burden on healthcare providers and ensuring that patients receive timely and tailored healthcare advice. This AI-driven interface enhances the accessibility and personalization of healthcare, embodying HealthLynked’s commitment to leveraging technology for better health outcomes. The company recently launched HealthLynked 3.2.0, an advanced version of its application, incorporating telemedicine, AI-driven personal healthcare guidance, and remote patient monitoring – setting a new standard in healthcare technology.

Market Position and Future Outlook

According to Facts and Figures Research, a research and consulting firm, the global market for patient-centric healthcare applications is projected to reach $41.6 billion by 2030, growing at a CAGR of 18.77% from 2022. HealthLynked’s offerings align perfectly with this expansive market opportunity, especially with increasing demands for digital health solutions and data management in healthcare.

HealthLynked’s strategic direction, spearheaded by its seasoned management team, is designed to leverage these market dynamics, enhancing patient engagement and healthcare efficiency on a global scale.

Management Team

Michael T. Dent, M.D., Founder, CEO, and Chairman, brings extensive experience from his foundational role at NeoGenomics and leadership in various healthcare and technology sector companies.

David Rosal, CFO, with previous senior roles at Teradata and McDonald’s Corporation, brings a wealth of expertise in financial and business integration strategies essential for growth and operational efficiency.

Chris Hall, CTO, with a strong background in global technology development from his time at Siemens and several patents to his name, is instrumental in driving the innovation and technological advancement at HealthLynked.

Bill Crupi, Operations Manager, has a proven track record in streamlining operations and enhancing productivity across multiple sectors within the healthcare industry. His expertise is crucial in maintaining the operational excellence that HealthLynked is known for.

Michael Paisan, Director of Investor Relations, leverages his extensive experience in finance and communications to enhance HealthLynked’s relationships with investors and stakeholders, ensuring transparent and effective communication of the company’s value and growth strategy.

Gagan Babber, Manager of Software Development, oversees the HealthLynked development teams based in the U.S. and India. With a robust background in engineering and software development, he plays a critical role in guiding the technological direction of HealthLynked’s products. His expertise in developing scalable, innovative software solutions is essential for driving the company’s technical initiatives forward and ensuring that HealthLynked stays at the forefront of digital healthcare technology.

HealthLynked Corp. (OTCQB: HLYK), closed Friday's trading session at $0.058, off by 15.942%, on 690,475 volume. The average volume for the last 3 months is 124,424 and the stock's 52-week low/high is $0.033/$0.0999.

Recent News

Coyuchi Inc.

The QualityStocks Daily Newsletter would like to spotlight Coyuchi Inc.

Studies carried out by Oxford Economics and Cognizant Research determined that businesses in the United Kingdom are planning to increase what they spend on sustainability by 13% annually between next year and 2030. This comes as more companies work to offset and cut emissions, decrease use of paper, adopt EV schemes and improve traceability in their supply chains. While these initiatives are helping drive positive change for the environment and society as a whole, what isn't clear is whether companies are also working to minimize the use and wastage of water to boost their environmental, social and governance ("ESG") efforts. Understanding and decreasing the use of water is an important part of any environmental strategy of a company. Companies that haven't already done so are encouraged to consider the effect their water use could have on both sustainable business goals and a company's bottom line. Looking for ways to optimize water use is something that entities such as Coyuchi Inc. will see immediate bottom-line benefits in, and it would also supercharge their efforts to entrench various components of ESG in their operations.

Coyuchi is the gold standard in sustainable luxury home goods. The company offers sustainably produced luxury organic bedding, sheets, towels, apparel, and other home goods for the environmentally conscious home. With a timeless, coastal-inspired aesthetic, Coyuchi uses only 100% organic cotton materials to manufacture all of its textiles.

The Company was built upon four foundational pillars: protect the planet, innovate circular design, live sustainably, and enrich the community. These guiding principles have proven an effective market strategy. In 2021, Coyuchi earned $33.3 million in net sales, amounting to 26% YoY growth (the industry average is only 5%). It also experienced 2x customer growth to 200,000 active customers, averaging a 35% customer repeat purchase rate.

With a seasoned leadership team, a robust e-commerce shopping experience, and a healthy customer base that drives the fast-growing organic luxury market, Coyuchi is prepared to propel a new phase of growth as the rest of the world finally awakens to sustainability at scale.

A Lucrative Market Ripe for the Taking

The global market for organic bedding, which was estimated at $814.3 million in 2020, is projected to reach $1.1 billion by 2027, growing at a CAGR of 4.9% over that period, according to Research and Markets. More specifically, the domestic organic bedding market is estimated at $240.1 million in 2020, according to Statista. Overall, the U.S. market for home textiles is currently valued at $25 billion annually, and, with a forecast annual growth rate of 5%, it is expected to reach $30 billion by the end of 2025.

Grand View Research reported in 2020 that shifting consumer preference toward high-end lifestyle products is a key factor driving the growth of the organic bedding market. Seventy-four percent of consumers are willing to pay more for sustainable products – a consumer preference that has steadily increased over the last few decades. Millennials especially favor ethical consumption over price when purchasing goods and services, with 83% of millennials reporting that they want the brands they purchase from to align with their beliefs and values (https://ibn.fm/PANNV). With a majority millennial customer base, Coyuchi is poised to capitalize on this trend.

Industry Defining Sustainability Practices

For 30 years, Coyuchi has explored organic farming and sustainable textiles and guarantees the highest environmental and ethical standards through a number of certifications such as The Global Organic Textile Standard (GOTS), Fair Trade Certified, and MADE SAFE®.

Coyuchi continues to push the organic textile market forward through its circularity initiatives and by supporting cross-industry sustainability advocates. Coyuchi’s mission to bring beauty and comfort to every home without sacrificing the health of our planet has resulted in a number of important sustainability checks and balances.

  • A Circular Business Model: Coyuchi has cultivated a holistic 360-degree approach that contributes to the fight against climate change with its take back and recycling program, 2nd Home™. In 2017, it became the first luxury home brand to implement such an initiative, and, since then, the company has eliminated 68,758 lbs. of toxic chemicals from homes and renewed 6,000 lbs. of textiles.
  • The Coyuchi Climate Council: In early 2022, Coyuchi introduced a cross-disciplinary council with a goal of Net Zero Emissions by 2025 and Net Positive Emissions by 2030. The Coyuchi Climate Council brings together influential minds across fashion, regenerative farming, and sustainability who have the knowledge and experience necessary to achieve climate change.
  • C4: The California Cotton & Climate Coalition: Most recently, Coyuchi announced it is a founding member of C4, which includes innovative, sustainable fashion, apparel, and personal care brands like MATE the Label, Outerknown, Reformation, and Trace. Working together pre-competitively, C4 creates a structure for investing in regionally grown, Climate Beneficial™ cotton and directly supports the livelihoods of the farmers that grew it. Coyuchi is the only home industry brand currently involved in the project.

Omnichannel Business Model

Coyuchi differentiates itself through an omnichannel and circular business model, both of which have proven a clear draw for customers. It was an early adopter of an e-commerce sales and marketing approach (over 80% of its sales are directly through coyuchi.com), creating a distinct advantage over incumbents and start-up newcomers in the luxury space. This has resulted in a high lifetime value customer, luxury retail partners such as Nordstrom, and a flagship store in Marin County.

Coyuchi’s Organic Textile Products

Coyuchi’s product assortment consists of consciously designed bedding, bath, apparel, and lifestyle products spread across about 1,400 SKUs. The company believes that its product assortment, produced from 100% organic cotton with Global Organic Textile Standard (GOTS) certification, provides it with a significant competitive advantage. GOTS is the world’s leading textile processing standard for organic fibers, ensuring the organic status of textiles after harvesting raw materials through environmentally and socially responsible manufacturing all the way to labeling, a major environmental and social benefit over conventional cotton product production.

Coyuchi’s focused product assortment consists of four core categories:

  • Bedding – A full suite of sustainable, organic, and high-quality sheets, duvet covers, blankets, and throws.
  • Bath – A luxurious line of towels, bath rugs, and mats.
  • Apparel – Premium apparel for men and women, including robes, sweaters, pants, and pajamas.
  • Lifestyle – The lifestyle category offers 135 SKUs, from organic napkins to crossbody totes.

Management Team

Eileen Mockus is President and CEO at Coyuchi. She has more than 25 years of experience in retail, having held positions in textile development at Patagonia, Pottery Barn Teen, and The North Face. She earned a bachelor’s degree in textiles and clothing from UC Davis and an MSBA from San Francisco State University.
Sejal Solanki is Chief Marketing Officer at Coyuchi. She previously served as the company’s Vice President of E-Commerce. Before joining Coyuchi, she worked at teen clothing giant Charlotte Russe. She oversees the company’s digital marketing, site experience, brand marketing, and e-commerce strategy.

Marcus Chung is Coyuchi’s COO, overseeing supply chain, sourcing strategy, sustainability, and IT. He previously held positions at notable direct-to-consumer brands Third Love and Stitch Fix, as well as national retailer The Children’s Place. He holds a bachelor’s degree from Wesleyan University and an MBA from UC Berkeley’s Haas School of Business.

Margot Lyons is Director of Sustainability and Sourcing at Coyuchi, where she works with strategic partners to ensure all the company’s product sustainability standards are met. She received a master’s degree in textiles and clothing from UC Davis.

Use of Proceeds

This round of funding will be used to increase Coyuchi’s enterprise value through expanded marketing, product category expansion, continued physical presence, and B2B strategic partnerships with wholesalers, and online marketplaces.

Recent News

chart

Astiva Health

The QualityStocks Daily Newsletter would like to spotlight Astiva Health

In America, Medicare Advantage is increasing in popularity among beneficiaries of Medicare. Insurers under this version of Medicare offer lower premiums, with dental and vision coverage added on. Jointly, more than 50% of eligible recipients of Medicare are on private plans. However, a recent report from KFF determined that there were huge differences between enrollment in Medicare Advantage in the northern and southern counties of California. Data from the Centers for Medicare & Medicaid Services shows that market penetration for Medicare Advantage was considerably lower in northern counties in comparison to southern counties. The KFF report determined that between 2021 and 2022, prior authorization requests denied by Medicare Advantage rose to 7.4% from 5.8%. In total, 3.4 million requests were denied. Companies such as Astiva Health offering Medicare Advantage coverage in California have plenty to do to bring on board all those who are still outside the system so that these individuals can also benefit from value-added services.

Astiva Health is a dynamic and innovative Medicare Advantage Prescription Drug (MAPD) health plan committed to reshaping the landscape of personalized and comprehensive healthcare. The company offers full medical, drugs, and supplemental benefits for Medicare enrollees, currently serving counties in California, including Orange, San Diego, Los Angeles, Riverside, and San Bernardino. This broad coverage reflects Astiva Health’s dedication to reaching a diverse demographic and addressing the healthcare needs of individuals across Southern California.

Astiva Health primarily serves a heretofore underserved Asian American and Pacific Islander population, which positions it in a critical and expanding market segment and offers substantial growth potential. The company recognizes the diverse needs within its served communities and strives to bridge healthcare gaps through proactive and culturally responsive solutions.

Astiva Health cares about its members and works to establish lifelong relationships with them by providing a tailored approach to healthcare, offering multilingual solutions for customer service, marketing materials and educational resources. Health is an essential key to living a good life, and Astiva Health makes it a priority to help members love the life they live.

The company’s mission is to deliver an unparalleled level of quality care to its members. Astiva Health’s Medicare Advantage plans provide lower costs and additional benefits beyond original Medicare coverage.

Founded in southern California, Astiva Health has strategically positioned itself in a region with a dynamic and diverse population. The organization’s extensive network and culturally responsive approach to healthcare make it well-suited to cater to the needs of the local community, creating a competitive advantage in the market.

The company is based in Orange, California.

Healthcare Model

Astiva Health is not just another health plan. The company considers the uniqueness of its members and, therefore, the means for delivering quality care to each one. To best serve its members, Astiva Health has developed one of the most diverse networks in southern California, offering a selection of medical, drugs, and supplemental benefits including dental, acupuncture, vision and hearing plans tailored to the specialized needs of individual members.

The company’s health plans provide increasing levels of benefits to members in the counties it serves. Astiva Health’s Customer Care Support and representatives are available to assist members with any issues.

The organization’s proactive approach to overcoming language barriers for the Vietnamese communities demonstrates a commitment to inclusivity and enhances accessibility – a key factor for future growth. The successful implementation of strategies for the Vietnamese community sets a precedent for Astiva Health’s ability to adapt and apply similar approaches to serve other ethnic groups in future expansions, broadening the potential impact of its services.

The company provides members access to experienced and dedicated providers and local pharmacies that work together with each member to pave a pathway toward better health. The company’s online directory provides members with a comprehensive list of providers to fit their specialized needs.

Astiva Health collaborates with a variety of partners who offer supplemental benefits to members beyond Medicare. Those benefits include transportation, vision, dental, hearing, fitness, tele-health, acupuncture and chiropractic. Astiva’s forward-thinking strategy not only fulfills a critical societal need but also ensures sustainable growth and transformative impact across diverse communities.

Market Opportunity

Medicare Advantage plans, since their establishment in 2008 as a lower-cost alternative for Medicare enrollees looking to save on monthly premiums, have been one of the fastest growing segments of the health insurance market.

According to a report by healthcare consultant Charts, nearly 31 million beneficiaries are enrolled in a Medicare Advantage plan in 2023, accounting for more than 48% of the total Medicare market. That represents 9.6% enrollment growth over 2022 totals, and the pace of growth is likely to continue, according to the Charts report.
Startup Medicare Advantage plans, a sector that includes Astiva Health, grew even faster for 2023, at a rate of 22% over 2022 totals.

Management Team

Dr. Tri T. Nguyen is co-founder and CEO of Astiva Health. He is a graduate of Stanford Medical School and is a board-certified expert in internal medicine, cardiovascular disease and interventional cardiology. As founder, CEO and owner/operator of Avanta IPA, he is a committed leader in healthcare. His visionary leadership, hands-on experience and deep industry knowledge uniquely position him to guide Astiva to success.

Chi Luong is CFO at Astiva Health. She founded and operates HADD Group LLC, a company managing medical clinic services, including business contracting, finance, staffing and ancillary support for several medical clinics in San Diego. She is responsible for the expansion and daily operation of the business functions of the medical clinics managed by HADD Group, and she has extensive knowledge and experience in healthcare business development.

Viet Tran has over 30 years of experience in engineering research, development and management. He has made numerous contributions to national network security and technology. He led the initial Naval Interoperability Profiles that set a solid foundation for future naval airborne network development. He also led a team of 50 engineers, doctorates and scientists delivering an airborne network system for the Navy’s first carrier-based unmanned aircraft. As Astiva Health’s Chief Operating and Technology Officer, member satisfaction has been his top priority. He is committed to protecting valuable data for Astiva members and providers. He constantly strives for leaner and more effective operations.

Tyler Diep is Vice President, Sales, Marketing and Provider Relations at Astiva Health. His responsibilities include handling special projects for the board of directors, as well as overseeing the sales, marketing and provider relations department. During his tenure, he tripled the membership of Astiva Health. He previously served as councilman and vice mayor of the City of Westminster, California. He immigrated to the U.S. with his parents and graduated from San Diego State with a bachelor’s degree in public administration.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.